



BACULOVIRUS-MEDIATED GENETIC MODIFICATION 





















BACULOVIRUS-MEDIATED GENETIC MODIFICATION 









A THESIS SUBMITTED 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
DEPARTMENT OF BIOLOGICAL SCIENCES 
NATIONAL UNIVERSITY OF SINGAPORE 
AND 





First of all, I would like to express my gratitude to my supervisor, Dr. Wang 
Shu, Associate Professor, Department of Biological Science, National 
University of Singapore and Group Leader, Institute of Bioengineering and 
Nanotechnology, for his continuous support and patient supervision during 
my entire post-graduate study period.  
 
I would also like to acknowledge our excellent gene delivery group at the 
Institute of Bioengineering and Nanotechnology for providing a fantastic 
environment and an exceptional research atmosphere for the study. 
 
Special acknowledgments go to Dr. Zeng Jieming for his patient 
cooperation and many useful discussions regarding my research project, and 
to Dr. Wu Chunxiao for his helpful suggestions for experiments and critical 
review of this thesis. 
 
This thesis is dedicated to my father Du Weijun and my mother Tian Lihua, 





TABLE OF CONTENTS 
Contents                                 Page 
ACKNOWLEDGMENTS .................................................................................. I 
TABLE OF CONTENTS.................................................................................. II 
SUMMARY....................................................................................................VII 
LIST OF PUBLICATIONS..............................................................................IX 
LIST OF TABLES ...........................................................................................X 
LIST OF FIGURES.........................................................................................XI 
ABBREVIATIONS........................................................................................XIII 
 
CHAPTER ONE: INTRODUCTION................................................................. 1 
1.1 General Introduction ........................................................................ 2 
1.1.1 Human Embryonic Stem Cells.................................................. 2 
1.1.2 Non-Viral Genetic Modification Systems for hES Cells ............ 3 
1.1.3 Viral Vectors for Genetic Modification of hES Cells.................. 4 
1.1.4 Baculovirus Vectors Mediated Gene Delivery .......................... 5 
1.2 Purpose of This Study ..................................................................... 7 
1.3 Specific Objectives........................................................................... 8 
CHAPETR TWO: ENGINEERING TRANSGENE EXPRESSION 
CASSETTES FOR EFFICIENT AND TRANSIENT BACULOVIRAL 
TRANSDUCTION OF HUMAN EMBRYONIC STEM CELLS ....................... 11 
2.1 Introduction .................................................................................... 12 
 III
2.1.1 Current Status of Transient Transgene Transfer in hES Cells 12 
2.1.2 Promoters for Transgene Expression in Mammalian Cells..... 13 
2.1.3 Viral Genetic Modulators ........................................................ 14 
2.1.4 Objectives .............................................................................. 15 
2.2 Material and Methods..................................................................... 16 
2.2.1 Transfer Plasmids and Baculovirus Preparation .................... 16 
2.2.2 Maintenance of hES cells and Baculoviral Transduction........ 19 
2.2.3 FACS Analysis ....................................................................... 21 
2.2.4 Immunocytochemistry ............................................................ 21 
2.3 Results ............................................................................................ 22 
2.3.1 Optimization of Baculoviral Transduction Method .................. 22 
2.3.2 Baculoviral Vectors Effectively Mediate Gene Transfer to hES 
Cells ................................................................................................ 24 
2.3.3 Various Promoters Show Differential Efficiency for Baculoviral 
Transduction of HES-1 .................................................................... 27 
2.3.4 WPRE, not ITR Sequences, Efficiently Enhanced Baculoviral 
Transduction of HES-1 .................................................................... 30 
2.3.5 A Hybrid Promoter Further Improved Baculoviral Transduction 
of HES-1.......................................................................................... 33 
2.3.6 Transgene Expression Cassettes Optimized in HES-1 Also 
Displayed Better Efficiency for Baculoviral Transduction of HES-3 
and Differentiated HES-1 ................................................................ 35 
 IV
2.3.7 Baculoviral transduction of hES cells was transient and had no 
effect on cell proliferation in vitro..................................................... 37 
2.4 Discussion ...................................................................................... 39 
CHAPTER THREE: HYBRID BACULOVIRUS VECTORS FOR 
LONG-TERM STABLE TRANSGENE EXPRESSION.................................. 45 
3.1 Introduction .................................................................................... 46 
3.1.1 Hybrid Viral Vectors................................................................ 47 
3.1.2 Objectives .............................................................................. 48 
3.2 Materials and Methods................................................................... 49 
3.2.1 Plasmid Construction and Virus Preparation.......................... 49 
3.2.2 Cell Line Maintenance and Transduction ............................... 51 
3.2.3 Maintenance and Differentiation of hES cells ......................... 52 
3.2.4 Viral Transduction and FACS analysis ................................... 54 
3.2.5 Genomic DNA isolation and Nested PCR .............................. 55 
3.2.6 TAIL-PCR............................................................................... 58 
3.3 Stable Transgene Expression is Obtained in A Cell Line and in 
hES Cells: the Single-Vector Approach.............................................. 62 
3.3.1 Hybrid Baculovirus Vectors Mediated Stable Transgene 
Expression in NT2 Cells .................................................................. 62 
3.3.2 Hybrid Baculovirus Vectors Mediated Stable Transgene 
Expression in hES Cells .................................................................. 64 
 V
3.3.3 Transgene Expression is Maintained During hES Cell 
Differentiation .................................................................................. 67 
3.3.4   Nested PCR and TAIL PCR Were Employed To Detect 
Sequences Flanking the Integrated Transgene Cassette................ 70 
3.4 Stable Transgene Expression is obtained in A Cell Line and in 
hES Cells: A Co-transduction Approach............................................ 73 
3.4.1 Sustainable transgene expression can be achieved by 
co-transduction of ITR-and rep-containing baculoviral vectors........ 73 
3.4.2 Nested-PCR Detection of the Transgene Integration Sites on 
Chr19 in the Genomic DNA of Stably Transduced HeLa Cells........ 77 
3.4.3 Hybrid Baculovirus Vectors Mediated Stable Transgene 
Expression in hES Cells .................................................................. 81 
3.4.4 Analysis of hES Genomic DNA Samples by Nested-PCR, 
TAIL-PCR and the DNA Walking Speed Up Kit............................... 82 
3.5 Discussion ...................................................................................... 84 
CHAPTER FOUR: THE EFFECTS OF BACULOVIRAL TRANSDUCTION 
ON HUMAN EMBRYONIC STEM CELLS .................................................... 87 
4.1 Introduction and Objective ............................................................ 88 
4.2 Materials and Methods................................................................... 88 
4.2.1 Vector Construction and Virus Preparation ............................ 88 
4.2.2 Maintenance and Differentiation of hES Cells ........................ 89 
4.2.3 Viral Transduction .................................................................. 91 
 VI
4.2.4 Reverse Transcription-PCR Analysis ..................................... 91 
4.2.5 Immunohistochemistry and Karyotypic Analysis..................... 93 
4.2.6 Teratoma Formation............................................................... 93 
4.3 Baculoviral Transduction Has No Effects on hES Cells’ Stem 
Cell Properties ...................................................................................... 94 
4.3.1 Baculoviral Transduction Did Not Affect hES Cell Growth...... 94 
4.3.2 Baculoviral Transduction Did Not Change hES Phenotype.... 95 
4.3.3 Baculoviral Transduction Did Not Affect hES Cell Pluripotency97 
4.4 Discussions .................................................................................. 103 
CHAPTER FIVE: CONCLUSION................................................................ 104 
5.1 Results and Implications ............................................................. 105 
5.1.1 Efficient and Controlled Transient Transgene Expression Can 
be Achieved by Using Different Promoters and Genetic Modulators105 
5.1.2 Hybrid Baculovirus Vectors Allow Stable Transgene 
Expression .................................................................................... 106 
5.1.3 Baculoviral Transduction Has No Effects on the Stem Cell 
Properties of hES Cells ................................................................. 107 




The main purpose of the studies in this thesis was to explore and engineer 
baculoviral vectors for the genetic modification of human embryonic stem 
cells.  
Although lentiviral vectors are widely used in gene transfer to human 
embryonic stem cells, there is still a need for vectors and methods to achieve 
efficient and safe genetic modification of these cells. Our studies employed 
baculovirus vectors to mediate transgene expression, either transiently or 
stably, as the tools for genetic modification. 
First, we engineered the baculovirus vectors by choosing various 
promoters and viral modulators to achieve desirable level of transient 
transgene expression in human embryonic stem cells. Efficient gene 
transfers to human embryonic stem cells were obtained after optimization of 
the promoters and modulators.  
Second, two elements from adeno-associate virus, ITR sequence and the 
rep gene were inserted into the baculovirus vectors together with transgene 
expression cassette. We achieved stable transgene expression in human 
embryonic stem cells for up to 5 moths. We also characterized the integration 
sites of the transgene expression cassette. 
 VIII
Finally, the effects of the baculoviral transduction of the human embryonic 
stem cells were investigated. The transduction of human embryonic stem 
cells by baculovirus vectors had no effects on the cell growth and 
pluripotency. The formation of teratoma in vivo further confirmed the 
pluripotency of the transduced cells.    
In summary, the information gained from this research suggest that 
baculovirus vectors can be engineered to mediate both transient and stable 
expression in human embryonic stem cells for the purpose of genetic 
modification, thus facilitating the realization of  the great potential of these 
cells in basic researches and clinical applications. 
 IX
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1.1 General Introduction 
Embryonic stem (ES) cells as a renewable cell source for regenerative 
medicine, for pharmaceutical research and development and for 
developmental biology studies, are currently the subject of intensive research. 
Genetic manipulation of these cells with an effective gene delivery strategy is 
of great importance in making use of the remarkable potential of ES cells. 
Possible benefits of genetic manipulation include controlling differentiation of 
ES cells, screening and acquiring pure populations of specific types of ES 
cell-derived cells, altering antigenicity of cells to overcome immune rejection 
in transplantation medicine, and providing cell sources with new functional 
properties to combat specific diseases in the course of ex vivo gene therapy. 
1.1.1 Human Embryonic Stem Cells 
Human embryonic stem (hES) cells are cells derived from the inner cell 
mass of human blastocysts. The hES cell research began with the derivation 
of hES cell line and its successful culture in the laboratory (Thomson et al., 
1995). Human embryonic stem cells possess two characteristic properties, 
self-renewal and differentiation capability. Self-renewal allows hES cells to be 
kept in culture and passaged long-term under defined culture conditions 
without loss of their pluripotency. This property of self-renewal will supply 
research and clinical applications with an unlimited cell source. The other 
interesting feature of hES cells is their differentiation potentials. hES cells are 
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able to differentiate into all the cell types in the body, that is, the cells are 
pluripotent. These two properties make human embryonic stem cells 
promising and attractive for use in regenerative medicine and studies of 
human development as well as for pharmaceutical screening.  
1.1.2 Non-Viral Genetic Modification Systems for hES Cells  
In order to realize the great potential of hES cells, efficient and safe 
methods need to be developed to deliver genes or proteins into these cells. 
The delivery of genes or proteins or certain factors to give stem cells new 
genetic characteristics is called genetic modification. The genetic 
modification of hES cells can be helpful in the differentiation and isolation of 
lineage-committed cells, in tracking the process of differentiation, in gene 
function analysis, and in altering immunogenecity. To achieve successful 
genetic modification, safe and efficient gene delivery systems are crucial. 
Non-viral and viral systems have been developed and optimized for use in 
genetic manipulation.  
Non-viral delivery systems, using naked DNA or synthetic 
oligonucleotides directly, or genes or proteins encapsulated with lipids, 
peptides or polymers, are widely favored because of their safety. Low toxicity 
is the most attractive advantage of the non-viral delivery systems. However, 
they can only achieve a certain level of efficiency of transgene or protein 
delivery, while viral vectors are well known for their high delivery efficiency. 
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Chemically based gene transfection and antibiotic selection have been 
performed in order to establish stable human ES cell lines (Eiges et al., 2001), 
but the method’s gene transfer efficiency and the efficiency of subsequent 
homologous recombination in human ES cells are low. Electroporation, a 
method of choice for introducing foreign DNA into mouse ES cells, can be 
adapted for the gene transfection of human ES cells (Zwaka and Thomson, 
2003). With nucleofection, an electroporation-based method using specific 
transfection solution and electrical parameters to deliver plasmid DNA into the 
cell nucleus, a transfection rate of 20% could be achieved in human ES cells 
(Lakshmipathy et al., 2004). However, electroporation protocols that give 
satisfactory transfection efficiency are usually detrimental to cells and hES 
cells do not survive the procedure well (Eiges et al., 2001).  
1.1.3 Viral Vectors for Genetic Modification of hES Cells  
Modified viruses are also used to deliver transgenes both in vitro and in 
vivo, mainly due to their high transduction efficiency. Various viruses have 
been investigated and modified for use as delivery vectors, including 
retroviruses, adenoviruses (Ads), adeno-associated viruses (AAVs), and 
herpes simplex viruses (HSVs).  
Among these commonly used viral vectors, HIV-based lentiviral vectors 
were the first and most widely used viral vectors for the genetic modification 
of hES cells because of their high gene delivery efficiency and their ability to 
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mediate stable transgene expression during prolonged undifferentiated 
proliferation in vitro for an observation period of at least 38 weeks (Eiges et 
al., 2001; Gropp et al., 2003; Ma et al., 2003). Besides lentivirus vectors, 
adenoviral and adeno-associated viral (AAV) vectors are also able to infect 
human ES cells (Smith-Arica et al., 2003). Although the potential application 
of these viral vectors is enormous, concerns still remain over their 
immunogenecity in medical use, especially with regard to recombination with 
endogenous viruses, oncogenic chromosome insertion associated with 
random integration, non-selective cytotoxicity and pre-existing immune 
responses against the viruses. Furthermore, vector size for gene cloning may 
be another limiting factor for certain applications that require large transgene 
cassettes. Thus, there is still a great need for efficient and safe vectors for the 
genetic modification of hES cells.  
1.1.4 Baculovirus Vectors Mediated Gene Delivery 
In addition to the commonly used viral vectors mentioned above, the 
insect cells baculovirus Autographa californica multiple nucleopolyhedrovirus 
(AcMNPV)-based vectors are relatively new and have recently emerged as a 
promising gene delivery vector capable of efficiently transferring genes of 
interest to diverse mammalian cell types (Ghosh et al., 2002; Kost and 
Condreay, 2002). The ability of baculovirus to enter certain mammalian cell 
lines was firstly reported by Volkman and Goldsmith in 1983, while no 
evidence of viral gene expression was observed in their study. Later studies 
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showed that recombinant viruses containing a promoter that is active in 
mammalian cells could be used to transduce such cells, and could therefore 
potentially be used as gene delivery vectors for mammalian cells. Carbonell 
and Miller (1987), using baculovirus with a mammalian gene expression 
cassette, detected reporter enzyme activity in a human lung carcinoma cell 
line. Baculoviruses with CMV promoter were shown by Condreay and 
colleagues to infect a broad spectrum of cell lines (Condreay et al., 1999). 
Recently, baculovirus has also been successfully used as vector to deliver 
genes into the CNS (Sarkis et al., 2000).  
As one of the most promising gene delivery vectors, baculovirus has a 
number of advantages.  First, baculovirus has a good biosafety profile. The 
investigation of the interaction between baculovirus and mammalian cells has 
indicated that baculovirus can enter but cannot replicate in mammalian cells 
(Carbonell et al., 1985; Carbonell and Miller, 1987; Groner et al., 1984; Hartig 
et al., 1992).  Thus, no particular attention needs to be paid to the risks 
associated with replication-competent virus, a major problem in the use of 
adenovirus vectors as in vivo gene delivery vectors. However, further studies 
will be required to determine whether any of the viral genes are expressed in 
mammalian cell (Boyce and Bucher, 1996). Second, baculovirus can 
accommodate large insertions (>20 kb). The rod-shaped AcMNPV has a 
double-stranded, circular DNA about 130 kb in size and the nucleocapsid 
structure can accommodate up to 100 kb of foreign DNA. This enables the 
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delivery of large functional gene or of multiple genes simultaneously.  Third, 
baculovirus shows broad cell-type tropism. More than 40 commonly used cell 
lines, including some primary cultures, have been reported to be successfully 
transduced (Ghosh et al., 2002; Kost and Condreay, 2002).  Moreover, 
baculovirus is non-cytotoxic even it was used at high multiplicity of infection 
(MOI).  Fourth, baculovirus is simple to manipulate and produce. The 
AcMNPV vectors are helper virus independent; thus, it is relatively easy to 
construct baculovirus vector with various transgene cassette and obtain large 
quantities of high-titer virus stock.  
Although lentivirus vectors are the most successfully and widely used 
vectors for the genetic modification of human embryonic stem cells, the 
random nature of their chromosomal integration has raised safety concerns 
and the cloning capacity limitation of lentivirus vectors limits the size of the 
transgene that can be delivered. Therefore, new vectors that can mediate 
efficient and safe gene transfer to hES cells are needed. Based on the 
advantages of baculovirus vectors as described above, in this study, we 
undertook this study to investigate the suitability of baculovirus as a viral vector 
for the genetic modification of hES cells.  
1.2 Purpose of This Study 
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This thesis will focus on the exploration of baculovirus as a vector for the 
genetic modification of hES cells, both for transient transgene expression and 
for long-term transgene expression.  
First, we constructed baculoviral vectors containing various promoters 
and viral modulators to achieve different transduction efficiencies and 
transgene expression intensities in hES cells. Second, we constructed 
baculovirus vectors to which we added two AAV elements to mediate stable, 
prolonged transgene expressions and investigated chromosome integration 
sites to address the genotoxicity of these hybrid viral vectors. Third, the 
effects of baculoviral vectors were examined using various approaches in 
vitro and in vivo to test the effects of this viral vector on the proliferation and 
differentiation of hES cells. 
1.3 Specific Objectives 
The main investigation of this research can be organized into three parts: 
1. Baculovirus was firstly demonstrated to mediate transgene expression 
in human embryonic stem cells and baculovirus vectors were then 
genetically engineered with choice of promoters and viral modulators to 
achieve various delivery efficiencies and different level of transgene 
expression as vectors for transient transgene expression. 
2. Baculoviral vectors that incorporated the two AAV elements were 
constructed to become hybrid viral vector and stable transgene 
 9
expression by these hybrid vectors were observed for a prolonged period 
and characterized.  
3. The effects of baculoviral transduction on hES cells were investigated 
to determine whether the baculovirus could be used as safe viral vector 
for the genetic modification of ES cell. In vitro and in vivo assays were 
used to test the effects of baculoviral transduction on the self-renewal and 
differentiation properties of ES cells.  
This study demonstrated that baculovirus is an efficient and safe vector 
for the genetic modification of hES cells both for transient transgene 
expression and for stable transgene expression, thus making baculovirus an 
alternative viral vector (if not better than lentiviral vectors), for the genetic 
modification of ES cells. By incorporating different promoters and viral 
modulators or transgenes, baculoviruses can be used to achieve gene 
transfer into hES cell thus facilitating stem cell research. In addition, 
baculovirus can be employed to deliver factors or proteins that may direct the 
differentiation of hES cells to obtain specific lineages. Moreover, baculovirus 
could be used to deliver functional or therapeutic genes into human 
embryonic stem cells and their derivatives. The genetically modified hES 
cells and derivatives could be probably be applied in cell-based therapy to 
restore lost functions, diminish abnormal cell population or repair damaged 
tissues. 
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In the next chapter, we explore the use of baculovirus vectors as genetic 
modification tools for mediating transient transgene expression.  
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CHAPTER TWO  
ENGINEERING TRANSGENE EXPRESSION CASSETTES 
FOR EFFICIENT AND TRANSIENT BACULOVIRAL 
TRANSDUCTION OF HUMAN EMBRYONIC STEM CELLS 
 12
2.1 Introduction 
hES cells hold great potential as a system for the study of lineage 
specification and as an unlimited source of cells for the regenerative 
medicine. To meet these needs, direction differentiation of hES cells is 
crucial, which involves the upregulation and downregulation of certain 
differentiation-related genes within a very short time period (Hay et al., 2004; 
Hyslop et al., 2005; Kawabata et al., 2005; Mossman et al., 2005; 
Smith-Arica et al., 2003). Thus, a gene delivery vector which can mediate 
transgene expression transiently and efficiently is of great importance for 
directing differentiation and lineage commitment (Eiges et al., 2001; 
Lakshmipathy et al., 2004; Liew et al., 2007; Siemen et al., 2005). 
2.1.1 Current Status of Transient Transgene Transfer in hES Cells 
Although various non-viral and viral gene delivery methods have been 
developed for the genetic modification of hES cells, none of the existing 
vectors have been proved to be efficient and useful for transient transgene 
expression in these cells. Non-viral methods offer transient expression of the 
transgene, but the low efficiency and the cytotoxicity of the methods are 
problematic. Viral vectors derived from adenovirus and AAV have shown low 
efficiency in hES cells transduction (Smith-Arica et al., 2003). Lentiviral 
vectors are still the most successful and efficient vectors which are used for 
the genetic modification of hES cells. However, these vectors mediate 
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persistent transgene expression by random integration into chromosomes. 
The random nature of the integration raises biosafety concerns, due to the 
possibility of insertional mutagenesis (Hacein-Bey-Abina et al., 2003; 
Schroder et al., 2002; Wu et al., 2003) and reduces the likelihood of lentiviral 
vectors being used for efficient transient transgene expression. 
2.1.2 Promoters for Transgene Expression in Mammalian Cells 
The choice of promoter has always been an important issue for gene 
delivery, as it greatly affects the quantitative expression of the transgene as 
well as the slicing of the transcripts. Promoters such as CAG, PGK, EF1α, 
U3, CMV, TK and Oct4 have been used in a limited list of viral or non-viral 
vectors for the genetic modification of hES cells (Strulovici et al., 2007). 
Oct4 is a transcription factor with a central regulatory role in controlling of 
pluripotency of embryonic stem cells and is widely used as a hES 
cell-specific marker (Mountford et al., 1998; Ying et al., 2003). Comparatively 
little work has been done on the use of the human Oct4 promoter to drive 
transgene expression in hES cells. One study has demonstrated the activity 
of an exogenous Oct4 promoter in driving the expression of eGFP gene in 
stable hES cell clones (Gerrard et al., 2005). 
The CMV promoter is a strong viral promoter widely used for transgene 
expression in many cell types. It has been commonly used to drive the 
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transgene expression in hES cells, mostly in non-viral vectors to yield low or 
moderate levels of transgene expression (Yael, Philip et al., 2007). 
The promoter of the house-keeping gene EF1α is a popular choice for 
genetic manipulation of hES cells (Strulovici et al., 2007). In a recently 
published study, lentiviral vectors containing the EF1α promoter provided 
gene expression in 14.74% of hES cells, higher than the efficiency of 3.69% 
provided by a lentiviral vector equipped with the CMV promoter (Kim et al., 
2007). 
A hybrid promoter approach can be applied to improve promoter strength, 
resulting in high level of transgene expression in mammalian cells. The SV40 
enhancer and CMV enhancer, strong viral enhancers of small size, are both 
commonly fused with promoters of low transcriptional activity to enhance 
their strength (Niwa et al., 1991; Sawicki et al., 1998). The inclusion of the 
CMV enhancer upstream of the EF1α promoter has proven to be 4-9 fold 
more efficient in activity than a construct lacking the CMV enhancer 
(Kobayashi et al., 1997).  
2.1.3 Viral Genetic Modulators 
Besides promoters, other DNA elements are also used to regulate 
transgene expression in mammalian cells. The AAV 145bp inverted terminal 
repeats (ITR) sequence was placed flanking the transgene cassette, the 
cassette demonstrated higher transgene expression efficiency. Although the 
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mechanism is not clear but the effects of the ITRs were attributed to mRNA 
stabilization. Researchers have reported that transgene expression 
efficiency in mammalian cells is improved by the use of ITR sequences to 
flank the transgene expression cassette in viral vectors or plasmids 
(Chikhlikar et al., 2004; Costantini et al., 2000; Johnston et al., 1997; Lam et 
al., 2002; Philip et al., 1994; Vieweg et al., 1995; Xin et al., 2003). 
Insertion of the woodchuck hepatitis virus posttranscriptional regulatory 
element (WPRE) into lentiviral vectors with the EF1α promoter has been 
reported to increase transgene expression in hES cells (Gropp et al., 2003; 
Pfeifer et al., 2002). When AAV vectors were used to transduce rat neurons, 
incorporation of WPRE enhanced transgene expression from the CMV 
promoter, the neuron-specific enolase promoter, and the CAG promoter 
(Klein et al., 2002; Loeb et al., 1999; Xu et al., 2001). These findings suggest 
that the beneficial effect of the viral WPRE element on gene expression is 
probably promoter-independent. Interestingly, the use of WPRE in the above 
animal studies also prolonged gene expression. 
2.1.4 Objectives 
The aim of this study was to develop a baculoviral vector for efficient and 
transient transgene expression in hES cells. The activities of various 
promoters were compared and the delivery efficiency of baculovirus vectors 
with a combination of viral genetic modulators was also investigated. The 
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optimized vectors developed in this study can be used to deliver transcription 
factors or regulatory proteins in order to facilitate or direct the differentiation 
of hES cells. 
2.2 Material and Methods 
2.2.1 Transfer Plasmids and Baculovirus Preparation 
The transfer plasmid pFastBac1 (pFB, Invitrogen, Carlsbad, CA, 
http://www.invitrogen.com) was used to accommodate the eight different 
expression cassettes studied (Table 2.1) and to generate recombinant 
baculoviruses. To construct the transfer plasmid pFB-CMV.eGFP, the human 
cytomegalovirus (CMV) immediate early gene promoter and enhancer (CMV 
promoter) and enhanced green fluorescent protein (eGFP) gene from 
pEGFP-C1 (Clontech, Mountain View, CA, http://www.clontech.com) were 
inserted between the BamHI and EcoRI sites of pFastBac1. To construct the 
transfer plasmid pFB-Oct4.eGFP containing the Oct4 promoter, the human 
Oct4 promoter fragment was cut from pOct4-PGL-3 basic (kindly provided by 
Professor NG Huck Hui, Genome Institute of Singapore, Singapore) with 
BglII and Agel and inserted between the BamHI and AgeI sites of 
pFB-CMV.eGFP to replace the CMV promoter. The transfer plasmid 
pFB-EF1α.eGFP containing the human elongation factor-1α promoter (EF1α 
promoter) was cloned by inserting a human elongation factor-1α (EF1α) 
promoter from pEF1V5-HisA (Invitrogen) between the BamHI and EcoRI 
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sites of pFastBac1. Next, the enhanced green fluorescent protein (eGFP) 
gene from pEGFP-C1 was amplified using the forward primer 
5’-CAAGGAATTCCGCCACCATGGTGAGCAA-3’ and the reverse primer 
5’-ATTACTAGTCTACTTGTACAGCTCGTC-3’ by the polymerase chain 
reaction (PCR) and inserted between the EcoRI and SpeI sites. 
The transfer plasmid pFB-EF1α.eGFP-WPRE that incorporates the 
woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) 
was constructed by replacing the eGFP gene in pFB-EF1α.eGFP with the 
eGFP-WPRE fragment from psubCMV-eGFP-WPRE (kindly provided by 
Professor H Büeler, University of Zurich, Switzerland). To produce 
pFB-EF1α.eGFP+ITRs and pFB-EF1α.eGFP-WPRE+ITRs, which contain 
expression cassettes flanked by AAV ITR sequences, the EF1α promoter 
from pEF1V5-HisA (Invitrogen) was inserted between the KpnI and HindIII 
sites of a previously described plasmid pAAV-MCS-luc (Wang et al., 2005) 
and the eGFP gene or the eGFP-WPRE fragment was used to replace the 
luc gene between the HindIII and XbaI sites. To construct the transfer 
plasmids pFB-eCMV.EF1α.eGFP and pFB-eCMV.pEF1α.eGFP-WPRE, 
which include the hybid promoter, the CMV immediate early gene enhancer 
fragment was PCR-amplified from pEGFP-C1 and inserted into 
pFB-EF1α.eGFP and pFB-EF1α.eGFP-WPRE upstream of the EF1α 












a. cassettes with various promoters
b. cassettes with virus-derived genetic modulators









 Figure 2.1 Transfer plasmids with different transgene expression 
cassette for the production of baculovirus vectors. 
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Baculoviral vectors carrying the above expression cassettes were 
produced and propagated in Sf9 insect cells according to the Bac-to-Bac 
Baculovirus Expression System manual (Invitrogen). Budded viruses in the 
insect cell culture medium were filtered through 0.2 μm pore size filters 
(Millipore, Billerica, MA, http://www.millipore.com) to remove any cell debris, 
and concentrated by centrifugation at 28,000 g for 60 min. Viral pellets were 
re-suspended in 0.1 M phosphate-buffered saline (PBS) and their infectious 
titers (plaque-forming units, pfu) were determined using a plaque assay on 
Sf9 cells. 
2.2.2 Maintenance of hES cells and Baculoviral Transduction  
Two hES cell lines HES-1 (NIH code: ES01) and HES-3 (NIH code: 
ES03)(Reubinoff et al., 2000), both of which are listed on National Institutes 
of Health (NIH) Human Embryonic Stem Cell Registry, were used. These two 
hES cell lines and their feeder cells K4 mouse embryonic fibroblasts (mEFs) 
were obtained from ES Cell International (ESI Singapore, 
http://www.escellinternational.com). A protocol provided by ESI was used to 
amplify and maintain these two cell lines. Both HES-1 and HES-3 cells used 
for baculoviral transduction experiments were further amplified on mitotically 
inactivated mEFs (CF-1 from American Type Culture Collection, Manassas, 
VA, http://www.atcc.org) seeded in gelatin (Sigma-Aldrich, St. Louis,  
http://www.sigmaaldrich.com) -coated dishes in 80% knock-out DMEM 
(Invitrogen) supplemented with 20% knockout serum replacement 
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(Invitrogen), 2 mM L-glutamine (Invitrogen), 0.1 mM non-essential amino 
acids (Invitrogen), 0.1 mM 2-mercaptoethanol (Invitrogen), 4 ng/mL basic 
fibroblast growth factor (Invitrogen), 50 U/mL penicillin, 50 
µg/mLstreptomycin as described before(Zeng et al., 2007). The hES colonies 
were subcultured every 7 days by mechanical slicing and replating into 
culture dishes with fresh mEFs. 
During transduction, baculoviral vectors in 100 l PBS were added at a 　μ
desired multiplicity of infection (MOI) to a suspension of HES-1 or HES-3 cell 
clumps in 50 l knock　μ -out DMEM. After transduction for 2 h, the hES cell 
clumps were washed with PBS and further cultured. For routine transduction 
experiments, hES cell clumps of normal size isolated at the time of 
subculturing were used and replated on mEFs in the above-mentioned 
medium after transduction. To facilitate fluorescence-activated cell sorting 
(FACS) analysis of multiple samples, the hES cell clumps were mechanically 
cut to a size of about 200 cells per clump for transduction and the transduced 
clumps were replated and cultured with a feeder-free method by seeding onto 
Matrigel (BD Biosciences, Bedford, MA, 
http://www.bdbiosciences.com )-coated plates in 80% knock-out DMEM 
supplemented with 20% knockout serum replacement, 2 mM L-glutamine, 0.1 
mM non-essential amino acids, 0.1 mM 2-mercaptoethanol, 40 ng/mL basic 
fibroblast growth factor, 50 U/mL penicillin, 50 µg/mLstreptomycin (Xu et al., 
2005).  
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2.2.3 FACS Analysis 
Two days after transduction, the transduced hES cells were washed in 
PBS, trypsinized into single cells, and analyzed using a FACSCalibur flow 
cytometer (BD Biosciences). The use of eGFP as a reporter allows the 
evaluation of baculoviral transduction efficiency using both the percentage of 
eGFP-positive cells and the mean fluorescence intensity (MFI) of eGFP. The 
results of the FACS analysis are given as mean ± standard deviation (SD) 
from three to five experiments and were analyzed using Student’s t-test. 
2.2.4 Immunocytochemistry  
For hES cell immunofluorescence staining, the transduced hES cells were 
washed with PBS and fixed with ice-cold absolute methanol for 15 min. This 
was followed by permeabilization with PBS containing 0.1% Triton X-100 for 
30 s and blocking with 1% BSA in PBS for 30 min. The samples were then 
incubated with primary monoclonal antibodies against the hES cell marker 
TRA-1-60 (Santa Cruz Biotechnology, Santa Cruz, CA, http://www.scbt.com) 
for 1 h. After washing, a goat anti-mouse IgM-PE (Santa Cruz Biotechnology) 
secondary antibody was used for localization. To detect eGFP protein, Alexa 
Fluor 488 labeled- rabbit anti-GFP antibody (Invitrogen Molecular Probes) 
was included for double immunostaining. The samples were counterstained 
with Hoechst before observation. 
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2.3 Results 
2.3.1 Optimization of Baculoviral Transduction Method 
   There are two commonly used transduction methods for viral transduction: 
adherent transduction and suspension transduction. Since baculovirus 
vectors have been routinely applied to mammalian cells by the adherent 
method, we tested this method first with HES-1 cells. hES cells were cultured 
on mEFs and transduced with baculoviruses containing a EGFP reporter 
gene at desired MOI in serum-free medium at 37ºC for 1 h. On day 1 after 
infection, mass transgene expression was observed in the feeder mEF cells 
at a MOI of 50 (Figure 2.2a), suggesting that the virus preparation was of 
good quality. On day 2, there were a few cells with detectable transgene 
expression in the hES colonies, representing no more than 1% of the total 
hES cells (Figure 2.2b). hES cells grown on feeder displayed a much lower 
percentage of transgene expression compared with the feeder cells, 








Figure 2.2 Baculovirus-mediated transgene expression in HES-1 cells 
grown on feeders. The hES cells grown on feeders were infected with 
recombinant baculovirus containing the EGFP gene under control of the 
CMV promoter at MOI 200. Overlaying of phase-contrast and fluorescence 
images (left) and fluorescence microscopy images (right) of a hES cell 
colony on day 1 after infection to show transduced cells. On the bottom, a 





2.3.2 Baculoviral Vectors Effectively Mediate Gene Transfer to hES 
Cells 
We isolated hES cell clumps of the HES-1 line by mechanical slicing, 
suspended them in serum-free hES cell culture medium and transduced the 
clumps with baculoviral vectors containing an eGFP gene at an MOI of 100 
for 2 h before replating on feeders. Using a baculoviral vector incorporating 
the human EF1α promoter, we observed eGFP expression as early as 6 h 
after transduction. The expression became intense at 24 h, with bright green 
fluorescence observed throughout the clumps (Figure 2.3a). hES cells in the 
clumps maintained outgrowth after transduction, resulting in colonies with a 
central ‘green’ region surrounded by newly generated, eGFP-negative hES 
cells (Figure 2.3a, Day 4). This finding suggests that the virus was unable to 
replicate and to deliver its genome to hES cell progeny. The eGFP signals in 
the central region decreased over time (Figure 2.3a, Day 1-6) and became 
very weak after day 6. Using baculoviral vectors with both the 
EF1α promoter and 　 the WPRE, up to 80% of the cells in the infected hES 
cell clumps were eGFP-positive at day 2 as analyzed by flow cytometry 
(Figure 2.3b); while using baculoviral vectors with the CMV promoter or the 
human EF1α promoter without the WPRE, the transduction efficiency was 
approximately 25 to 40% (Figure 2.3b). The baculoviral vectors were also 
able to transduce embryoid bodies derived from hES cells (Figure 2.3c). We 
conclude that baculoviral vectors are effective in transducing not only 
 25






Figure 2.3 Transient eGFP expression in hES cells mediated by 
baculoviral vectors. (a) A time-course observation shows one hES cell 
colony 1, 2, 4 and 6 days after transduction with a recombinant baculovirus 
harboring the EF1α promoter at an MOI of 100. Phase-contrast (left), 
fluorescence (middle) and overlaying of phase-contrast and fluorescence 
(right) images are shown. (b) Flow cytometric analysis of eGFP-positive 
hES cells 2 days after baculoviral transduction at an MOI of 100. From top 
to bottom, recombinant baculoviral vectors accommodating the CMV 
promoter, the EF1α promoter, and the EF1α promoter plus WPRE were 
used respectively. The percentages of eGFP-positive cells are indicated. (c) 
An embryoid body transduced with the recombinant baculovirus with the 
CMV promoter at an MOI of 20. Phase-contrast (left) and fluorescence 
(right) images depict eGFP expression on day 1 after transduction. 
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2.3.3 Various Promoters Show Differential Efficiency for Baculoviral 
Transduction of HES-1 
Promoter activities vary in different types of cells. To choose a proper 
promoter for baculoviral transduction of hES cells, we investigated the 
efficiencies of baculoviral vectors containing one of the following three 
representative promoters of different derivations: a hES cell-specific promoter 
(the human Oct4 promoter), a viral promoter (the CMV promoter) and a cellular 
housekeeping gene promoter (the human EF1α promoter). These promoters 
were used to drive eGFP expression in HES-1 cells in the context of 
baculoviral vectors at an MOI of 100 and the transduction efficiencies were 
evaluated using FACS analysis 2 days after virus infection. As estimated by 
the percentage of eGFP-positive cells (Table 2.1 & Figure 2.4), the EF1α  　
promoter provided a transduction efficiency of 45%, being much stronger than 
the Oct4 promoter (24%) and the CMV promoter (22%). Moreover, the use of 
the EF1α promoter yielded the highest mean fluorescence intensity of eGFP, 
which was 1.5- and 6-fold higher than that provided by the CMV promoter and 
the Oct4 promoter respectively (Table 2.1 & Figure 2.4). These findings clearly 
indicate that the choice of promoter can make a significant difference not only 





















Figure 2.4 Flow cytometric analysis of transgene expression in 
HES-1 cells mediated by baculoviral vectors carrying different 
promoters. Small hES cell clumps were isolated mechanically and 
transduced. These clumps were then seeded on Matrigel-coated plates 
for 2 days before analysis. Abbreviations: CMV: the human 
cytomegalovirus immediate early gene promoter and enhancer; EF1α: 
the human elongation factor-1α promoter; eGFP: enhanced green 
fluorescent protein gene; Oct4: the human Oct4 promoter. See Table 
2.1 for the summary of analysis results. 
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2.3.4 WPRE, not ITR Sequences, Efficiently Enhanced Baculoviral 
Transduction of HES-1 
In an attempt to improve the activity of the EF1α promoter-containing 
expression cassette, we incorporated virus-derived genetic modulators. The 
WPRE sequence originated from woodchuck hepatitis virus has been used to 
enhance the post-transcriptional processing of transgene mRNA and the 
subsequent export of mRNA to the cytoplasm from the nucleus (Zufferey et 
al., 1999). WPRE might also stimulate translation per se (Loeb et al., 1999). 
The ITRs of AAV have also been employed to enhance transgene expression 
by flanking an expression cassette (Chikhlikar et al., 2004; Liu et al., 2006). 
After placing the WPRE sequence at the 3’-end of the eGFP gene, we 
observed an improvement of baculoviral transduction; the percentage of 
eGFP-positive HES-1 cells increased from 45% without the WPRE to 66% 
using the WPRE and the eGFP expression level in the transduced cells as 
estimated using MFI increased from 506 to 855 (Table 2.1 and Figure 2.4d, 
2.5a). However, the ITRs did not improve the transgene expression in hES 
cells. On the contrary, including the sequences into the EF1α 
promoter-containing expression cassette reduced both the percentage of 
eGFP-positive cells and the eGFP expression level (Table 2.1 & Figure 2.5b 
and c). The use of the WPRE together with the ITRs could only partially 
rescue the transduction efficiency in hES cells. This result suggests that the 
posttranscriptional regulation conferred by the WPRE is well maintained with 
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the use of the EF1α promoter and that the effect of the ITRs in promoting 






















Figure 2.5 Flow cytometric analysis of transgene expression in HES-1 
cells mediated by baculoviral vectors carrying different expression 
cassettes (MOI 100). Small hES cell clumps were isolated mechanically 
and transduced at an MOI of 100. These clumps were then seeded on 
Matrigel-coated plates for 2 days before analysis. Abbreviations: EF1α: the 
human elongation factor-1α promoter; eGFP: enhanced green fluorescent 
protein gene; eCMV: the human cytomegalovirus immediate early gene 
enhancer; WPRE: the woodchuck hepatitis virus post-transcriptional 
regulatory element. See Table 2.1 for the summary of analysis results. 
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2.3.5 A Hybrid Promoter Further Improved Baculoviral Transduction of 
HES-1 
One strategy to improve transgene expression from a cellular promoter is 
to include a viral enhancer in the expression cassette (Liu et al., 2004; 
Sawicki et al., 1998; Yew et al., 2001). To further improve transgene 
expression in hES cells, we tested the feasibility of using the CMV immediate 
early gene enhancer to improve the activity of the EF1α promoter. A hybrid 
promoter, wherein a CMV immediate early gene enhancer was placed 
upstream of EF1α promoter, was used in the expression cassettes. This 
approach resulted in the transduction of 72% of HES-1 cells and a 2.3-fold 
upregulation of transgene expression over that achieved by the expression 
cassette containing the EF1α promoter alone (Table 2.1 & Figure 2.5d, e). 
To investigate whether the combination of a viral enhancer that functions 
at the transcriptional level and the WPRE sequence that works at 
post-transcriptional level might further improve the transgene expression in 
hES cells, we constructed an expression cassette that contains both 
elements and tested it in HES-1 cells. However, when using the virus with 
this cassette at an MOI of 100, we did not observe statistically significant 
improvement in the percentage of transduced cells or eGFP expression level 
as compared with the efficiencies provided by the viruses containing the 
cassette with the hybrid promoter only or the EF1α promoter plus WPRE 



















Figure 2.6 Flow cytometric analysis of transgene expression in HES-1 
cells mediated by baculoviral vectors carrying various expression 
cassettes (MOI 10). Small hES cell clumps were isolated mechanically and 
transduced at MOI of 10. These clumps were then seeded on 
Matrigel-coated plates for 2 days before analysis. Abbreviations: EF1α: the 
human elongation factor-1α promoter; eGFP: enhanced green fluorescent 
protein gene; eCMV: the human cytomegalovirus immediate early gene 
enhancer; WPRE: the woodchuck hepatitis virus post-transcriptional 
regulatory element. See Table 2.1 for the summary of FACS results. 
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In view of the possibility that a high MOI in the above experiment might 
have led to the saturation of the gene expression machinery, a low MOI of 10 
was tested. As shown in Figure 2.6 and Table 2.1, the incorporation of the 
WPRE indeed further improved the efficiency of the hybrid 
promoter-mediated transduction at an MOI of 10, as evidenced by the 
increase in the percentage of eGFP-positive cells from 27% to 37%. 
2.3.6 Transgene Expression Cassettes Optimized in HES-1 Also 
Displayed Better Efficiency for Baculoviral Transduction of HES-3 and 
Differentiated HES-1 
To test whether the transgene expression cassettes optimized in HES-1 
can also be extrapolated to other hES cell lines, the transduction efficiencies 
of baculoviral vectors with these cassettes were examined in HES-3 cells. 
We noticed that overall levels of gene expression were lower in HES-3 cells 
as compared with those in HES-1 cells (Figure 2.7 and Table 2.1). This 
decline in expression level may be explained by the hES cell lines’ different 
sensitivities to baculoviral transduction. Nevertheless, the promoting effect of 
including the WPRE or the CMV immediate early gene enhancer in the EF1α 
promoter-containing expression cassettes was observed in HES-3, especially 
the combined use of the two elements significantly increased the percentage 
of eGFP-positive cells, even at an MOI of 100, over that seen using the 
cassettes containing either of the two elements alone (Figure 2.7 and Table 
2.1). The results from using a low MOI in HES-1 cells and a high MOI in 
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HES-3 cells confirm that the CMV immediate early gene enhancer and the 




















Figure 2.7 Flow cytometric analysis of transgene expression in 
HES-3 cells mediated by baculoviral vectors carrying various 
expression cassette. Small hES cell clumps were isolated 
mechanically and transduced at MOI of 100. These clumps were 
then seeded on Matrigel-coated plates for 2 days before analysis. 
Abbreviations: EF1α: the human elongation factor-1α promoter; 
eGFP: enhanced green fluorescent protein gene; eCMV: the human 
cytomegalovirus immediate early gene enhancer; WPRE: the 
woodchuck hepatitis virus post-transcriptional regulatory element. 
See Table 2.1 for the summary of these results. 
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2.3.7 Baculoviral transduction of hES cells was transient and had no 
effect on cell proliferation in vitro and teratoma formation in vivo 
To determine the time course of transgene expression after baculoviral 
transduction, HES-1 cell clumps of normal size isolated at the time of routine 
subculture were transduced and replated on mEFs. Figure 2.7 shows the 
HES-1 clumps 1-7 days after transduction with baculoviral vectors equipped 
with different expression cassettes. eGFP fluorescence become bright in the 
whole clumps as early as 1 day after transduction, dropped gradually from 
day 3 onwards and was almost undetectable by day 7. The expression 
cassettes with the WPRE element appeared to maintain the expression 
slightly longer. These findings demonstrate the transient nature of the 
baculoviral transduction of hES cells. The transduced clumps proliferated 
normally over the period, indicating that virus infection does not affect the 
self-renewal ability of hES cells (Figure 2.8). Furthermore, when these 
transduced cells were transduced again after growing on mEFs for 7 days 
with a baculoviral vector containing eCMV.EF1α.eGFP-WPRE, we still 
observed a transduction efficiency of 58%, suggesting that the transduced 
cells permitted repeated infections of baculoviral vectors. This feature also 
indicates the feasibility of using repetitive infections to flexibly manipulate the 
duration of gene expression. 
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Figure 2.8 HES-1 clumps 1-7 days after transduction with various 
baculoviral vectors. The transduced cells proliferated normally. 
Abbreviations: EF1α: the human elongation factor-1α promoter; eGFP: 
enhanced green fluorescent protein gene; eCMV: the human 
cytomegalovirus immediate early gene enhancer; WPRE: the woodchuck 
hepatitis virus post-transcriptional regulatory element. 
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2.4 Discussion 
The main finding of the current study was the importance of the design of 
a transgene expression cassette design in achieving efficient transduction in 
hES cells. Transgene expression cassettes can be optimized at both the 
transcriptional and post-transcriptional levels by selecting a proper promoter 
and active regulatory elements. Promoters such as CAG, PGK, EF1α, U3, 
CMV, TK and Oct4 have been used in a limited list of viral and non-viral 
vectors for genetic modification of hES cells (Strulovici et al., 2007). In the 
context of lentiviral vectors, transgene expression is suppressed in a 
promoter-dependent manner in hES cells, highlighting the importance of 
choosing an optimal promoter for genetic modification of hES cells (Xia et al., 
2007).  Here, we compared the activity of three representative promoters 
Oct4, CMV and EF1α in the context of baculoviral vectors in hES cells. Oct4 
is a transcription factor with a central regulatory role in controlling of the 
pluripotency of embryonic stem cells and is widely used as an hES 
cell-specific marker (Mountford et al., 1998; Ying et al., 2003). Comparatively 
little work has been done on the use of the human Oct4 promoter to drive 
transgene expression in hES cells. One study demonstrated the activity of an 
exogenous Oct4 promoter in driving the expression of eGFP in stable hES 
cell clones (Gerrard et al., 2005). As shown in our study, the activity of the 
Oct4 promoter was insufficient for meaningful transgene expression in 
transient transduction: this finding is probably related to the delicate role of 
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Oct4 in maintaining stem cell status. The CMV promoter is a strong viral 
promoter widely used for transgene expression in many cell types but in hES 
cells the use of this promoter is still far from satisfactory, as its activity is only 
slightly higher than that of the Oct4 promoter. The promoter from the 
house-keeping gene EF1α is a popular choice for genetic manipulation of 
hES cells (Strulovici et al., 2007). Our study further confirms that the EF1α 
promoter is superior to both the Oct4 and CMV promoters. In a recently 
published study, the authors used lentiviral vectors containing the EF1α 
promoter and achieved gene expression in 14.74% of hES cells, higher than 
the efficiency of 3.69% provided by a lentiviral vector with the CMV promoter 
(Kim et al., 2007). Nevertheless, as demonstrated in previous (Strulovici et al., 
2007) and current studies, using the EF1α promoter alone without the 
assistance of other regulatory elements will yield only low-to-moderate 
transduction efficiencies in hES cells. Obviously, low transduction efficiency 
presents an obstacle for therapeutic and experimental applications when 
delivered genes need to be expressed in the majority of cells. 
To enhance the transcriptional activity of the EF1α promoter, we adopted 
a hybrid promoter approach that fused the CMV immediate early gene 
enhancer to the EF1α promoter. Previous studies have demonstrated that 
appending a viral transcriptional regulatory element to a cellular promoter is a 
powerful approach to improve the strength of the cellular promoter (Liu et al., 
2004; Sawicki et al., 1998; Yew et al., 2001). One of the most successful 
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examples of a hybrid promoter composed of a viral enhancer and a cellular 
promoter is the CMV enhancer/chicken β-actin (CAG) promoter, which can 
significantly improve transgene expression in several tissues (Niwa et al., 
1991; Paterna and Bueler, 2002). The activity of the CAG promoter appears 
to vary among different hES cell lines. In H9 hES cells, a lentiviral vector with 
the CAG promoter and the central polypurine tract (cPPT) sequence yielded 
a transduction efficiency of 3.3%, lower than the efficiency of 18.6% when the 
EF1α promoter was used together with cPPT (Xia et al., 2007). However, in 
H1 hES cells, a lentiviral vector with the CAG promoter, cPPT and WPRE 
provided a reported efficiency of nearly 100% (Pfeifer et al., 2002). It has 
been reported that when tested in plasmid constructs, the CMV immediate 
early gene enhancer can stimulate the EF1α promoter and increase levels of 
transgene expression in COS-7 and NIH3T3 cells (Kobayashi et al., 1997). 
To our knowledge, our study is the first to use the hybrid promoter approach 
to augment transgene expression in hES cells. The mechanism underlying 
the enhancement is unclear, but it is probably related to a favorable 
interaction between the transcriptional factors and the auxiliary proteins 
normally attracted by the CMV immediate early gene enhancer and the 
tested cellular promoter. 
Incorporating the viral post-transcriptional regulatory WPRE sequence 
into our baculovirus vectors harboring the hybrid CMV immediate early gene 
enhancer/EF1α promoter led to further improvement in transgene expression 
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in hES cells. Insertion of WPRE into lentiviral vectors with the EF1α promoter 
has been reported previously to increase transgene expression in hES cells 
(Gropp et al., 2003; Pfeifer et al., 2002). When AAV vectors were used to 
transduce rat neurons, incorporation of the WPRE enhanced transgene 
expression from the CMV promoter, the neuron-specific enolase promoter, 
and the CAG promoter (Klein et al., 2002; Loeb et al., 1999; Xu et al., 2001). 
These findings suggest that the beneficial effect of the viral WPRE element 
on gene expression is probably promoter-independent. Interestingly, the 
WPRE used in the above animal studies also prolonged gene expression. 
The WPRE used in this hES cell study, however, appeared to be unable to 
change the dynamics of transgene expression significantly. With or without 
the WPRE sequences, hES cells transduced by the baculoviral vectors 
harboring the hybrid CMV immediate early gene enhancer/EF1α promoter 
displayed similar patterns of transient gene expression, decreasing toward 
the background level within one week irrespective of initial transgene 
expression levels. Several mechanisms might be responsible for the loss of 
expression. Baculovirus genomic DNA normally remains episomal in 
transduced cells. They cannot replicate in mammalian cells and would be 
diluted by cell division over time, resulting in the decrease of gene expression. 
Alternatively, baculovirus genomic DNA might activate the host cell defense 
machinery, which would ultimately eliminate the viral vector together with its 
gene expression cassette. Although the EF1α promoter is a cellular 
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transcription regulatory element with an authentic DNA sequence and should 
be less sensitive to promoter silencing, the CMV immediate early gene 
enhancer part of our hybrid promoter would still be subject to transcriptional 
silencing such as DNA methylation. As reported, transcriptional silencing can 
be caused by extensive methylation of the CMV promoter and enhancer 
following adenoviral gene transduction (Brooks et al., 2004). 
Among all the gene transfer methods currently tested in hES cells, 
lentiviral vectors pseudotyped with vesicular stomatitis virus G protein 
(VSV-G) have provided an efficient strategy for gene delivery (Strulovici et al., 
2007; Yates and Daley, 2006). In a previous study, use of the HES-1 cell line, 
the lentiviral vector equipped with the EF1α promoter, cPPT and the WPRE 
resulted in eGFP expression in 30-48% of the hES cells 7 days after 
transduction (Gropp et al., 2003). Our present study with baculoviral vectors 
showed up to 72% of HES-1 cells and 46% of HES-3 cells being transduced 
2 days after transduction (Table 2.1), indicating clearly that the efficiency of 
baculoviral transduction in hES cells is comparable to that offered by lentiviral 
vectors. Like many other non-integrating gene delivery methods, the 
baculoviral vectors drove transient transgene expression in hES cells. It is 
worth noting that efforts have been made to create nonintegrating lentiviral 
(NIL) vectors by disabling the integrase and altering the integrase recognition 
sequence (att) in the lentiviral long terminal repeat (Nightingale et al., 2006; 
Philippe et al., 2006; Saenz et al., 2004; Vargas et al., 2004; Yanez-Munoz et 
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al., 2006). These NIL vectors make use of the high transduction efficiency of 
lentiviral vectors in many types of cells, especially in non-dividing cells, yet 
provide temporary transgene expression. The development of the NIL 
vectors reflects the demand for vectors suitable for efficient but transient 
transgene expression. Another modification of lentiviral vectors is 
pseudotyping with baculovirus gp64 envelope glycoprotein (Kumar et al., 
2003; Schauber et al., 2004). These gp64 pseudotyped lentiviral vectors 
provide transduction efficiency comparable to that of VSV-G-pseudotyped 
vectors (Schauber et al., 2004), but have low cytotoxic effects on 293T virus 
producer cells, thus facilitating the large-scale production of high-titer lentivial 
vectors required for clinical and commercial applications (Kumar et al., 2003). 
In summary, we have developed a new approach to engineer gene 
expression cassettes using a viral transcriptional element in parallel with a 
viral post-transcriptional regulatory element. We have demonstrated the 
efficiency of the newly developed expression cassette in the context of 
baculoviral vectors for high-level and transient expression of transgenes in 
hES cells. In addition to transductions in situations in which transient gene 
expression is required, this baculoviral vector can easily be modified to 
include a selectable marker and be used to establish hES cell lines that 









HYBRID BACULOVIRUS VECTORS FOR LONG-TERM 
STABLE TRANSGENE EXPRESSION 
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3.1 Introduction 
Versatile gene transfer vectors capable of mediating either transient or 
prolonged transgene expression are required for the genetic engineering of 
hES cells for the purposes of both regenerative medicine and basic biological 
studies. Viral vectors are developed and widely used mainly because of their 
high efficiency in mediating transgene expression. HIV-1-based lentiviral 
vectors were the first viral vectors employed to genetically engineer hES cells 
(Pfeifer et al., 2002). Lentiviral vectors allow high transduction efficiency and 
stable transgene expression as they integrate into the host genome and are 
resistant to transcriptional silencing (Gropp et al., 2003; Ma et al., 2003; 
Pfeifer et al., 2002). However, due to the severe pathogenic effects of HIV-1 
replication in humans, the potential emergence of replication-competent 
retrovirus from HIV-1-based vectors raises concerns over their use in clinical 
settings. Moreover, random chromosomal integration of lentiviral vectors 
poses the risk of insertional mutagenesis, oncogene activation and cellular 
transformation. The development of leukemia in two children after gene 
therapy for SCID-X1 (Hacein-Bey-Abina et al., 2003) has led to intense 
scrutiny of this risk. Additionally, lentiviral vectors may not be suitable for 
transient transgene expression. Viral vectors derived from AAV have a much 
lower risk of insertional mutagenesis and have been tested in hES cells, but 
their transduction efficiencies are less satisfactory (Smith-Arica et al., 2003). 
Non-viral methods, such as chemical-based plasmid delivery and 
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electroporation, have also been used for gene transfer into hES cells (Eiges 
et al., 2001; Lakshmipathy et al., 2004). These methods, however, suffer 
from low levels of transient transfection or cause membrane damage. When 
combined with an antibiotic resistance gene and drug selection for stable 
clones, the non-viral methods lead to random chromosomal integration of the 
transgene. 
In Chapter2, we reported the results of our extensive testing of the 
delivery efficiency of baculoviral vectors. We found that baculovirus vectors 
can be engineered to yield different transgene expression levels for the 
genetic modification of hES cells, but that the expression was transient. In 
this chapter, we modified the baculovirus vectors to incorporate two elements 
from AAV to construct a hybrid viral vector for the stable expression of 
transgenes in hES cells. The resulting hybrid viral vectors make use of the 
high efficiency and large gene accommodation capacity of baculovirus and 
the integration characteristics of AAV that result from the inclusion of AAV 
ITR sequence and rep gene. 
3.1.1 Hybrid Viral Vectors 
The hybrid virus approach has been widely adopted in order to combine the 
advantage of various viral elements. Liu Qiang et al (2006) presented a hybrid 
virus approach by including the ITR and rep into Herpes Simplex Virus to yield 
an HSV/AAV hybrid amplicon vector that demonstrated enhanced stability of 
the transgene. They further improved the design by making use of Cre 
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recombinase to ensure the low expression level of the Rep protein in 
packaging cells while the expression of the Rep protein would be sufficient to 
mediate transgene integration when Cre recombinase was present. Stable 
transgene expression was observed in 22% of the transduced cells and 70% of 
transduced cells underwent Rep-mediated site-specific integration (Liu et al., 
2006). Fabio Palombo and colleagues reported that hybrid baculovirus vectors 
containing the ITR sequences and rep gene were able to mediate stable 
transgene expression in the tested cell line by integrating into the host cell 
genome, and that 41% of the integration events occurred at a site on 
chromosome 19 called AAVS1(Palombo et al., 1998). 
However, only several cell lines were tested in their study and there is no 
report of this AAV hybrid baculovirus approach being applied to hES cells. 
Retaining the advantages of baculovirus, such as its large accommodation 
capacity, ease of preparation, non-pathogenicity, and adding the ability of 
mediating long-term transgene expression resulting from inclusion of  
ITR/Rep, we found this hybrid baculovirus a promising tool for enabling 
long-term transgene expression in hES cells. 
3.1.2 Objectives 
In this chapter, we describe the construction and testing of 
baculovirus-based hybrid virus vectors that include the ITR and rep gene 
from AAV. Both the single-vector transduction and co-transduction methods 
were tested on hES cells to investigate their ability of affecting stable 
 49
transgene expression and determine whether site-specific integration can be 
achieved. 
The development of hybrid baculovirus vectors offers another approach 
to obtaining stable transgene expression in hES cells, while raising fewer 
safety concerns than the HIV-based lentivirus vectors. 
3.2 Materials and Methods 
3.2.1 Plasmid Construction and Virus Preparation 
To generate hybrid baculovirus vectors, recombinant pFastBac1 vectors 
containing the AAV rep 78/68 genes and ITR sequences were constructed 
through a multiple-step cloning procedure. A fragment of the pAAV plasmid 
containing an expression cassette with a multiple cloning site (MCS), a 
reporter gene encoding eGFP, a SV40 polyA signal, and two ITR sequences 
at both ends (Wang et al., 2005) was inserted between the AvrII and SalI 
sites of a pFastBac1 vector. Next, the CMV promoter from pRc/CMV2 or the 
EF1α　promoter from pEF1V5-HisA was inserted into the recombinant 
pFastBac1 between the KpnI and HindIII sites of the pFastBac1 vector. In the 
third step, a 4.4 kb fragment of the AAV type 2 genome from pSub201 (kindly 
provided by Professor R.J. Samulski, University of North Carolina) was 
amplified by PCR and inserted into another pFastBac1 vector at the RsrII site, 
from which a 1.5 kb fragment that contains the encoding sequence of Cap 
and Cap terminator was removed by digestion with ApaI. After the rest part of 
the second recombinant pFastBac1 was re-ligated, a 3.0 kb fragment from 
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this re-ligated vector was excised with RsrII and then inserted into the first 
recombinant pFastBac1. This 3.0 kb fragment contains the full sequence of 
the rep gene including p5, p19, p40, and the Rep terminator and was placed 
outside the ITRs in an antisense orientation with respect to the pPolh 
promoter of pFastBac1. 
For the co-transduction method, transfer plasmids were constructed 
separately. The transgene-containing cassette was constructed by inserting 
a neomycin-expression cassette driven by SV40 promoter into 
pHY-EF1α-EGFP using KpnI. The neomycin expression cassette was placed 
in antisense orientation relative to the polyhedrin promoter. Two Rep 
expression vectors were designed, containing the full length rep gene or the 
coding sequence of Rep78 only. The plasmid pFB-Rep was constructed by 
inserting the 3.0 kb full-length Rep gene RsrII fragment mentioned above into 
pFastBac1 at RsrII site. The plasmid pFB-EF1α-Rep78 was constructed by 
insertion of a Rep 78 PCR fragment from the above vector after cleavage 
with XbaI and NotI (Forward primer, ATGCCGGGGTTTTACGAG; Reverse 
primer, TTATTGTTCAAAGATGCA). The EF1α promoter was inserted to 
drive the expression of Rep78, as it had been proved efficient in HES-1 in our 
previous study. A tk polyA tail was also inserted downstream of the Rep78 
coding sequence to stabilize the mRNA. 
Recombinant baculoviruses with the above expression cassettes were 
produced and propagated in Sf9 insect cells according to the manual of 
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Bac-to-Bac Baculovirus Expression system Manual (Invitrogen). Budded 
viruses in the insect cell culture medium were filtered through a 0.2 μm pore 
size filter (Millipore) to remove any cell debris, and concentrated by 
centrifugation at 25,000 g for 60 min. Viral pellets were re-suspended in 
appropriate volumes of 0.1 M phosphate-buffered saline (PBS), and their 
infectious titers (plaque-forming units, pfu) were determined by plaque assay 
on Sf9 cells. 
3.2.2 Cell Line Maintenance and Transduction 
3.2.2.1 Cell Line Maintenance 
The NT2/D1 or HeLa cell line (ATCC) was grown in DMEM (Sigma) 
supplemented with 10% heat-inactivated FBS (Gibco), 100 units/ml penicillin 
and 100 ng/mL streptomycin (Gibco). 
3.2.2.2 Transduction of NT2 cells 
NT2/D1 cells were seeding into a 48-well plate at 2.5× 104 or a 96-well 
plate at 1.0× 104 per well 1 day before transduction. Shortly before infection, 
the medium was replaced with serum-free DMEM and concentrated 
recombinant baculoviruses were then added at the desired multiplicity of 
infection (MOI). After 1 h of incubation, the cells were washed with PBS and 
further incubated in normal culture medium for 4 d before collection. 
3.2.2.3 Stable Expression Assay of HeLa Cells 
2.5×104 HeLa cells in a 48-well plate were co-transduced with two 
baculovirus vectors harboring rep and EGFP transgene respectively or solely 
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with baculovirus vector containing the EGFP transgene. The cells were 
amplified in culture medium for 2 weeks. The cells were then trypsinized from 
culture dish and analyzed using a FACSCalibur flow cytometer (BD 
Biosciences). 
3.2.2.4 Colony Forming Assay of HeLa Cells 
HeLa cells in a 6-well plate were co-transduced with two baculovirus 
vectors harboring rep and the EGFP transgene respectively or solely with the 
baculovirus vector containing EGFP transgene. Cells were counted and 
plated at 2×104 per 60mm cell culture dish or 100mm cell culture dish 4 days 
post-transduction, and then cultured using selection medium with 400ng/ul 
Geneticin (Gibco) for 2 weeks. Colonies with green fluorescence were 
counted using a fluorescence microscope. Colonies were labelled and 
trypsinized from culture dish and transferred into a 96-well plate to expand. 
When cells in the 96-well plate become confluent, they were transferred to a 
24-well plate and 6-well successively and genomic DNA was extracted from 
2×106 cells. 
3.2.3 Maintenance and Differentiation of hES cells 
The NIH Human Embryonic Stem Cell Registry-listed hES cell line 
HES-1(Reubinoff et al., 2000) and its feeder cells (K4 mouse embryonic 
fibroblasts, mEFs) were obtained from ES Cell International (ESI; Singapore, 
http://www.escellinternational.com). The hES cells were amplified and 
maintained according to the protocol provided by ES Cell International. For 
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viral transduction experiments, this HES-1 line was cultured on mitotically 
inactivated mEFs (CF-1 from American Type Culture Collection, Manassas, 
VA, http://www.atcc.org) seeded in gelatine-coated dishes in 80% knockout 
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supplemented with 
20% Knockout Serum Replacement (Invitrogen), 2 mM L-glutamine 
(Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 0.1 mM 
2-mercaptoethanol (Invitrogen), 4 ng/mL basic fibroblast growth factor (bFGF) 
(Invitrogen), 50 U/mL penicillin, and 50 µg/mL streptomycin (Pomp et al., 2005). 
The hES colonies were subcultured every 7 days by mechanical slicing and 
replating into fresh feeder layers. To form embryoid bodies (EBs), hES cells 
were grown to form large colonies and detached by using 0.1 mg/ml Dispase 
(Invitrogen). The hES cell clumps were transferred to a 15-ml conical tube 
containing 10 ml of a differentiation medium consisting of 80% knockout 
DMEM, 20% fetal bovine serum (Hyclone, Logan, UT, 
http://www.hyclone.com), 2 mM L-glutamine, and 0.1 mM nonessential amino 
acids and allowed to settle to the bottom. The supernatant was removed. The 
cell clumps were resuspended in the differentiation medium and transferred to 
a Petri dish. The cells were fed every day by replacing half of the medium with 
fresh differentiation medium and were cultured for 1 week. 
The derivation of neurons from hES cells was achieved based on the 
method described by Reubinoff et al (Reubinoff et al., 2001). In brief, the hES 
cell differentiation was induced by prolonged culture for 3-4 weeks on feeders. 
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The distinct areas of uniformly white-gray and opaque appearance under 
dark-field stereomicroscopy were cut and dissected into small clumps of cells. 
These cell clumps were then transferred to low cell-binding six-well plates 
(Nalge Nunc International, Rochester, NY, http://www.nuncbrand.com) 
containing DMEM/ Ham’s F12 medium (1:1; Invitrogen) supplemented with 
B-27 (1:50; Invitrogen), 2 mM L-glutamine, 50 U/mL penicillin, 
50µg/mLstreptomycin, 20 ng/mL human epidermal growth factor (EGF) 
(Chemicon, Temecula, CA, http://www.chemicon.com) and 20 ng/mL bFGF 
(Chemicon). After culture for 1–3 weeks, round neural spheres were formed. 
The spheres were then plated into dishes coated with poly(D-lysine) 
(Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.com) and laminin 
(Sigma-Aldrich). Neuronal differentiation was induced by the withdrawal of the 
growth factors from the culture medium. 
3.2.4 Viral Transduction and FACS analysis 
For viral transduction, hES cell clumps in suspension were used in order 
to eliminate the effect of virus absorption by mEFs (Gropp et al., 2003). At the 
time of routine passage, hES cell clumps were isolated from hES colonies by 
mechanical slicing. For each transduction, eight hES clumps were 
suspended in 50 µl knock-out DMEM in a 1.5 ml eppendorf tube and 
baculoviral vectors in 50 µl PBS were added at an MOI of 100. After 
incubation for 2 h, the clumps were washed with PBS and replated onto fresh 
feeder mEFs. 
 55
FACS analysis was used to quantify the transduction efficiency of the 
baculovirus vectors. After Dispase digestion to detach hES cell colonies from 
the mEFs, the colonies were collected, washed in PBS, and trypsinized to 
single cells before FACS analysis. 
3.2.5 Genomic DNA isolation and Nested PCR 
Cells transduced with baculovirus was trypsinized and collected into 1.5 
ml eppendorf tubes. Genomic DNA was extracted using a DNeasy Tissue Kit 
(QIAGEN). The sequence of DNA in the AAVS1 site was determined by PCR 
by using nested primer pairs that flank the AAV-chromosome junction: 
primers1c (eGFP, 5’-ggcatcgacttcaaggaggacggcaacatc), and f1 (AAVS1, 
5’-gttgccagtctcgatccgccccg), were used in the first round of PCR amplification 
with genomic DNA as the substrate. After an initial incubation for 4 min at 
94°C, the reaction mixture was subjected to 30 cycles of PCR amplification 
for 1 min at 94°C, 1 min at 61°C, and 3 min at 72°C. One percent of the 
amplification product was diluted into a new reaction mixture containing a set 
of nested primers with the following sequences: primers2c (eGFP, 
5’-ggccgacaagcagaagaacggcatcaaggt), and f2 (aavs1, 
5’-ctgcctggccctggccattgt). The PCR parameters were the same as for the first 
amplification. 
Other transgene-specific primers and AAVS1 primers were also tested 
with genomic DNA from cells that stably expressed eGFP (Table 3.1). Some 
of the aavs1 primers were following published papers (Huser and Heilbronn, 
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2003; Palombo et al., 1998; Tsunoda et al., 2000; Yang et al., 1997). The 
annealing temperature was adjusted according to the Tm value of the 
primers pairs selected for each nested PCR. The primer binding sites are 
illustrated in Figure 3.4. 
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Table 3.1 Nested-PCR primers used for detection of integration sites on 
chromosome 19. 
























We also used thermal asymmetric interlaced PCR to detect the integrated 
transgene expression cassette. Transgene-specific primers together with 
arbitrary degenerated primers (Table 3.2) were added in three round of PCR. 
The PCR cycling parameters are listed in Table 3.3. 
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Table 3.2 Primers for TAIL-PCR. 
 







AD1 SWG AXA WGA A 
AD2 GTX CGA SWC AXA WGT T 
AD3 WGT GXA GWA XCA XAG A 
AD4 TGW GXA GWA XCA SAG A 
AD5 AGW GXA GWA XCA WAG G 
AD6 CAW CGI CXG AIA SGA A 
AD7 TCS TIC GXA CIT WGG A 
AD8 XTC GAS TWT SGW GTT 
AD primers are degenerate primers. X= A/G/C/T, S= G/C, W= A/T, I = inosine. 
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Table 3.3 TAIL PCR programs 
Primary TAIL PCR 
Step Temperature(℃) Time Remarks 
1 95.0 2 min  
2 94.0 30 s 
Ramping  1.5 ℃/sec 
72 ℃-94 ℃ 
3 62.0 1 min  
4 72.0 2 min 30 s  
Go to step2 and write 4 cycles(i.e. 4+1 cycles) 
5 94.0 30 s 
Ramping  1.5 ℃/sec 
6 25.0 3 min  
7 72.0 2 min 30 s 
Ramping  0.26 ℃/sec 
8 94.0 10s 
Ramping  1.5 ℃/sec 
72 ℃-94 ℃ 
9 64.0 1 min  
10 72.0 2 min 30 s  
11 94.0 10 s Ramping  1.5 ℃/sec 
12 64.0 1 min  
13 72.0 2 min 30 s  
14 94.0 10 s 
Ramping  1.5 ℃/sec 
15 44.0 1 min  
16 72.0 2 min 30 s 
Ramping  1.5 ℃/sec 
Go to step8 and write 14 cycles(i.e. 14+1 cycles)  
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Known as 15 supercycles 
18 72.0 5 min  
19 4.0 Hold  
Secondary TAIL PCR 
Step Temperature(℃) Time Remarks 
1 94.0 10 s 
Ramping  1.5 ℃/sec 
2 61.0 1 min 
 
3 72.0 2 min 30 s  
4 94.0 10 s Ramping  1.5 ℃/sec 
5 61.0 1 min  
6 72.0 2 min 30 s 
 
7 94.0 10 s Ramping  1.5 ℃/sec 
8 44.0 1min 
 
9 72.0 2 min 30 s 
Ramping  1.5℃/sec 
10 Go to step2 and write 4 cycles(i.e. 4+1 cycles) 
Also knows as 15 super cycles 
11 72.0 5 min  
12 4.0 Hold  
Tertiary TAIL PCR 
Step Temperature(℃) Time Remarks 
1 94.0 15 s 
Ramping  1.5 ℃/sec 
2 44.0 1 min 
 
3 72.0 2 min 30 s  
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4 Go to Step1 and write 29 cycles(i.e. 29+1 cycles) 
5 72.0 5 min  
6 4.0 Hold 
 
 
3.3 Stable Transgene Expression is Obtained in A Cell Line and in hES 
Cells: the Single-Vector Approach 
3.3.1 Hybrid Baculovirus Vectors Mediated Stable Transgene 
Expression in NT2 Cells 
NT2 cells were transduced with hybrid virus vector and subjected to flow 
sorting to enrich for cells positive for transgene (Figure 3.1a). The sorted 
cells were cultured for more than 2 months and maintained their EGFP 








Figure 3.1 Stable eGFP expression in NT2/D1 cells mediated by hybrid 
baculoviral vectors. NT2/D1 cells were seeded into a 48-well plate at 2.5× 
104 per well or a 96-well plate at 1.0× 104per well 1 day before 
transduction. Shortly before infection, the medium was replaced with 
serum-free DMEM and concentrated recombinant baculoviruses were 
then added at the desired multiplicity of infection (MOI). (a) Flow sorting to 
enrich GFP+ cell population. GFP+ cells were sorted into 6-well plate and 
further cultured for months. (b) NT2/D1 cells proliferated normally and 
remained GFP+ after sorting. 
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3.3.2 Hybrid Baculovirus Vectors Mediated Stable Transgene 
Expression in hES Cells 
Stable transgene expression is crucial for hES cell applications of in 
fundamental studies of early human development as well as regenerative 
medicine. To extend the duration of baculoviral vector-mediated transgene 
expression, we constructed hybrid baculoviral vectors (Figure 3.2a) by 
including the Rep 78/68 genes and ITR sequences from AAV(Palombo et al., 
1998). The large gene capacity of baculovirus vector allows the inclusion of 
these large elements into a single vector together with a transgene. These 
chimeric virus constructs take advantage of Rep-mediated site-specific 
integration into the AAVS1 site in human chromosome 19q13.3-qter by 
non-homologous recombination (McCarty et al., 2004). hES cells transduced 
with a hybrid baculoviral vector accommodating the EF1α promoter displayed 
weak eGFP expression for the first 3 days. By day 7, a significant portion of 
the cells had become eGFP-positive. The number of eGFP-positive hES cells 
in the colonies was increased by mechanical selection at the time for normal 
subculture, and after five rounds of selection almost the entire hES colony 
was eGFP-positive (Figure 3.2b). This finding demonstrates that the relatively 
high transduction efficiency of baculoviral vectors in hES cells and the large 
cloning capacity of the virus, which can accommodate the AAV rep/ITR 
system, allow the use of fluorescent protein expression from the vector to 
enrich the transduced hES cells through colour selection without the use of 
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antibiotics. The selected eGFP-positive hES cells continued to express the 
transgene over at least 20 passages without the transgene being silenced 
(Figure 3.2c) and almost all the cells in the hES cell colonies were 
eGFP-positive as analyzed by flow cytometry (Figure 3.2d), suggesting that 





Figure 3.2 Stable eGFP expression in hES cells mediated by hybrid baculoviral 
vectors. (a) Schematic representation of hybrid baculoviral vectors containing the 
AAV rep gene and ITRs that direct transgene integration into human chromosome 
19q. (b) The hES cell clumps were transduced with the hybrid baculovirus 
accommodating the EF1α promoter (MOI = 100) and replated onto fresh feeders. 
eGFP+ hES cells were isolated mechanically and replated onto fresh feeders 
every 7 days. Phase-contrast (left) and fluorescence (right) images taken at 2, 3, 5, 
and 6 weeks post-transduction demonstrate the enrichment of eGFP+ hES cells. 
(c) Phase-contrast (left) and fluorescence (right) images show the growth of a 
stable eGFP+ hES colony at week 22 after infection. (d) Flow cytometric analysis 
of eGFP+ hES colonies at week 16 after infection. The percentage of eGFP+ cells 
is indicated. 
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3.3.3 Transgene Expression is Maintained During hES Cell 
Differentiation 
To further examine the stability of transgene expression, we investigated 
whether eGFP expression could be preserved after the differentiation of 
stably transduced hES cells into neurons, one type of the representative cells 
from ectoderm, using an established protocol (Reubinoff et al., 2001). We 
constructed a hybrid baculoviral vector that includes the constitutively active 
CMV promoter (Figure 3.2a) to facilitate the visualization of eGFP expression 
in both undifferentiated and differentiated cells. hES cells stably transduced 
with this hybrid virus were overgrown on feeder cells for 4 weeks (Figure 3.3a) 
and neural spheres were then generated from the overgrown cells by 
incubation in suspension in the presence of bFGF and EGF for 1-3 weeks. 
The resulting neural spheres retained intense eGFP expression (Figure 3.3b). 
After the neural spheres were cultured on poly-D-lysine/laminin-coated 
dishes in the absence of the growth factors, they began to display a typical 
neural phenotype with extending neurites, yet retained the bright eGFP 
fluorescence (Figure 3.3c, d). The transgene was expressed in these 
differentiated cells for at least 50 days (the duration of the experiment). Cells 
subjected to the neural differentiation protocol were stained positively with 
antibodies against a neuronal marker and against GFP (Figure 3.3e). 
Besides the neural cells, eGFP-positive beating cardiomyocytes, a 
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representative type of cells from mesoderm, were also regularly observed 





 Figure 3.3 Maintenance of transgene expression after neural 
differentiation of human embryonic stem (hES) cells stably 
transduced with a hybrid baculovirus harboring a cytomegalovirus 
promoter-driven enhanced green fluorescent protein (eGFP) gene. 
Fluorescence images show an eGFP+ colony overgrown on feeders for 4 
weeks without subculture (A), green neural spheres generated from the 
overgrown hES cells (B), eGFP+ cells with neuronal morphology within a 
neural sphere after plating for 2 weeks and outgrowth of eGFP+ neurites 
from the neural sphere (C). (D): Neuron-like cells that have migrated out 
from neural spheres display eGFP in both their cell bodies and neurites. 
(E): Immunostaining shows the colocalization of neuronal marker 200 kDa 
neurofilament (red) and eGFP (green) in cells derived from the stably 
transduced hES cells. Abbreviation: GFP, green fluorescent protein. 
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3.3.4   Nested PCR and TAIL PCR Were Employed To Detect 
Sequences Flanking the Integrated Transgene Cassette 
Studies of the integration sites were summarized by Daniela Hu¨ser and 
colleagues(Huser et al., 2002). The integration sites (insert position) ranged 
from 384 bp to 2400 bp on AAVS1 site as determined by Kotin et al (Kotin et al., 
1992). We designed nested PCR primers based on the NCBI sequence (gi: 
261958) and together with those from on published papers, they were used as 










Figure 3.4 AAVS1 primer binding sites on chr19 (sequence GI 
number: 261958). The relative positions of the AAVS1-specific primers 
are indicated in blue. RBS, Rep binding site: 405-420; trs, terminal 
resolution site: 384-389. 
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Genomic DNA isolated from transduced NT2 cells and hES cells was 
used for nested PCR and TAIL PCR. The tested genomic DNA samples were 
first amplified with EGFP primers first to verify the presence of EGFP 
sequence. A transgene-specific primer and an AAVS1-specific primer were 
used for each round of nested PCR. Although bands of different sizes 
(ranging 200bp to more than 1kb) or a smear of ~1kb could be cloned into 
TOPO vectors, no EGFP-AAVS1 junction was detected from the 11 hES 
genomic DNA samples. This could be due to the limited number of DNA 
samples obtained. Since the hybrid baculovirus vectors developed for the 
single-vector approach did not include a drug resistance gene, the selection 
of the transgene-positive population could be done only by manual slicing. 
Due to the slow growth of hES cells, it was difficult to obtain clones that were 
genetically different, and the amplification of such clones is also 
time-consuming. Hence, an insufficient number of representative genomic 
DNA samples and the low integration efficiency might have prevented us 
from detecting the EGFP-AAVS1 junction in our experiment. 
TAIL PCRs were carried out with hES genomic DNA samples. The PCR 
products from TAIL PCR were not long enough to extend past the ITR 
sequence; thus, we were not able to detect any genomic sequence flanking 
the transgene expression cassette. Genomic DNA samples with higher DNA 
concentrations were needed for further analysis. 
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3.4 Stable Transgene Expression is obtained in A Cell Line and in hES 
Cells: A Co-transduction Approach 
Increasing the rate of stable integration of this hybrid system in hES cells, 
might be crucially dependent on the control of rep gene expression. Active 
and consistent expression of the rep gene could result in chromosomal 
instability or mobilization of the transgene (McCarty et al., 2004). We 
developed a co-transduction method by constructing baculovirus vectors that 
delivered rep gene and ITR-flanked transgene expression cassette, 
respectively. Thus, the ratio of rep gene to ITR-flanked transgene expression 
cassette can be controlled, and rep gene expression is transient thus 
reducing the chance of chromosomal instability or mobilization of the 
transgene. We also included a neomycin resistance gene into the transgene 
expression cassette to facilitate the selection of transgene positive cells by 
use of Geneticin. 
3.4.1 Sustainable transgene expression can be achieved by 
co-transduction of ITR-and rep-containing baculoviral vectors 
To test whether the co-transduction of the ITR-flanking transgene 
cassette and the Rep recombinase can mediate long-term transgene 
expression, flow cytometry was conducted 2 weeks post co-transduction. In 
contrast to the control, in which the background of strongly EGFP-expressing 
cells was gated to be 0.01% of the total (Figure 3.5a), the strongly 
EGFP-expressing population was 0.11% of the cells transduced with the 
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ITR-containing baculoviral vector alone (Figure3.8b). However, both 
co-transduced groups showed a much higher percentage of strongly 
EGFP-expressing cells (Figure 3.5 c and d), these being 3.22 % and 4.27 %, 
respectively. Since we had already found that transgene expression resulting 
from baculoviral transduction is transient, and because only 0.11 % of cells 
transduced with ITR-containing baculoviral vector were maintaining 
transgene expression 2 weeks after transduction, we attributed the increased 
percentage of strong transgene-expressing cells to stable expression 
resulting from the co-transduction of the ITR-and Rep-containing baculoviral 
vectors. 
This population of cells was considered to have stably integrated the 
transgene, as transgene expression would drop dramatically without the help 
of the Rep protein. The higher percentage of strongly EGFP-expressing cells 
among the co-transduced cells suggests that simultaneous delivery of the 
ITR-flanked transgene cassette and the rep gene can mediate stable 




Figure 3.5 Flow cytometric analysis of the EGFP+ population of HeLa 
cells co-transduced by ITR and Rep-containing baculoviral vectors. 
HeLa cells were plated into 96-well plates and transduced with different 
virus constructs. (a) Control. (b) HyV-EF1α-EGFP-neoR only. (c) 
HyV-EF1α-EGFP-neoR and BV-Rep. (d) HyV-EF1α-EGFP-neoR and 
BV-EF1α-Rep78. (c) and (d) continues on the next page. 
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Figure 3.5(continued) Flow cytometric analysis of the EGFP+ 
population of HeLa cells co-transduced by ITR and Rep-containing 
baculoviral vectors. HeLa cells were plated into 96-well plates and 
transduced with different virus constructs. (a) Control. (b) 
HyV-EF1α-EGFP-neoR only. (c) HyV-EF1α-EGFP-neoR and BV-Rep. (d) 
HyV-EF1α-EGFP-neoR and BV-EF1α-Rep78.  
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3.4.2 Nested-PCR Detection of the Transgene Integration Sites on 
Chr19 in the Genomic DNA of Stably Transduced HeLa Cells 
To precisely identify the integration site of the transgene cassette on 
chromosome 19, HeLa cells were plated and subjected to neomycin 
selection. Genomic DNA was extracted and amplification of 
transgene-AAVS1 junction was performed using nested PCR primers (Figure 
3.6). Bands obtained in this nested PCR indicate the insertion of the 










Figure 3.6 Detection of site-specific integration mediated by hybrid 
baculovirus vectors in HeLa cells by nested-PCR. HeLa cells were 
co-transduced with HyV-EF1a-EGFP-neoR and BV-Rep baculovirus 
vector at an MOI of 50 for both. GFP+ cells were selected with 400ng/ul 
Geneticin(Gibco) 4 days post-transduction and colonies were picked 
and propagated. Genomic DNA was extracted from 2×106 cells from 
each colony formed. Nested PCR was carried out to amplify the 
transgene and aavs1 junction. 1-7 to 1-10 indicate PCR products from 
different clones. The amplified bands were indicated with white arrows. 
The molecular size standards are indicated.  
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The junction of the transgene and the AAVS1 site is shown in Figure 3.10. 
These results indicate that co-transduction of the two baculoviruses, 
HyV-EF1α-EGFP-neoR and BV-Rep, can mediate site-specific integration 
into the expected site. Although the detailed mechanism is not clear, the 
integration should result from Rep78/Rep68 proteins and the ITR sequences 
flanking the transgene-expressing cassette. However, this result differs from 
that of a previous study (Fablo et al, 1998) in that the ITR sequence was 










The bands obtained from the second round of nested PCR were gel 
purified and sequenced. Sequences from the AAVS1 site are underlined. 









3.4.3 Hybrid Baculovirus Vectors Mediated Stable Transgene 
Expression in hES Cells 
Since the co-transduction method worked well in the cell line tested, we 
investigated its application in hES cells as a method of achieving stable 
transgene expression. GFP positive cells were observed at the boundary of 
the colony, indicating that newly generated hES cells were still positive for 
transgene expression (Figure 3.8). We attributed the maintenance of 
transgene expression by the co-transduction method to the ITR/Rep system 
carried by the two baculoviral vectors, since no GFP positive cells could be 
observed in the peripheral region of the hES colonies when only the 
ITR-flanked transgene expression cassette was delivered. However, since 
the two hES cell line used in this study, HES-1 and HES-3, cannot survive 
drug selection by Geneticin even at a concentration as low as 10ng/ul, it was 
impossible to obtain pure hES colonies by chemical selection. Mechanical 
slicing was used as the normal passage process to enrich the transgene 
positive cell population, and purer cell “colonies” were observed. Genomic 
DNA from five such “colonies” was analyzed by nested PCR, but no specific 
band can be seen on the agarose gel. This could be due to the fact that the 
integration efficiency is too low to be detected or to the impurity of the 
analyzed cell population. 
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3.4.4 Analysis of hES Genomic DNA Samples by Nested-PCR, TAIL-PCR 
and the DNA Walking Speed Up Kit  
Five hES cells genomic DNA samples were prepared using a DNeasy 
Tissue Kit. 100μg of such DNA was used for each PCR reaction. Neither 
EGFP-AAVS1 junction nor other genomic DNA sequence was detected. This 
result could also be attributed to the limited number of samples that could be 
obtained and tested. Although a drug selection marker was included into the 
transgene expression vector, the transduced hES cells were enriched by 
manually mechanical slicing. The mEFs cannot survive drug selection even 
at very low concentration so the chemical selection was still not suitable for 



















Figure 3.8 Stable expression of a reporter gene in hES cells can 
be achieved by co-transduction of hybrid baculoviral vectors. The 
hES cell clumps were transduced with the hybrid baculovirus 
accommodating the EF1α promoter at a fixed MOI 0f 50, and Rep 
baculovirus was co-transduced into hES cells at the desired MOI. 
Abbreviations. ITR: HyV-EF1α-EGFP-neoR. Rep: BV-Rep (p5).  
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3.5 Discussion 
This study has further highlighted the advantage of the large cloning 
capacity of baculovirus, which allows the incorporation of several additional 
functional and regulatory elements, such as the rep/ITR chromosome 
integration system of AAV, into one single vector in addition to 
accommodating an expression cassette. Many studies have confirmed that 
AAV and hybrid viral systems that include the rep gene and ITRs are 
preferentially integrated at the AAVS1 site in human chromosome 19 
(McCarty et al., 2004). Such chromosomal integration at a defined genetic 
locus is preferable to random integration for the purpose of stable transgene 
expression. The 4 kb AAVS1 site constitutes at least part of a transcription 
unit (Kotin et al., 1992). It is still unclear whether disruption of the AAVS1 by 
rep/ITR-mediated integration has any side effects. Nevertheless, the effects 
of integration at the AAVS1 site on cell functions can be determined 
empirically, providing potential advantages over random integration with its 
unpredictable consequences. Hence, baculoviral vectors will prove to be a 
powerful tool for genetic manipulation of hES cells. 
The chromosomal integration rate of a gene delivery system is one of the 
important issues for genetic modification of hES cells. In one early study, 
plasmids containing a drug resistance gene were used to transfect hES cells 
via Exgen, a chemical-based gene delivery method (Eiges et al., 2001). Under 
drug selection pressure for 14 days, stable clones could be produced at a rate 
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of 1/100,000. However, no long-term study was conducted to investigate the 
maintenance of transgene expression during hES cell self-renewal or after 
their differentiation. Lentiviral vectors are currently popular for use in the stable 
genetic engineering of hES cells. Lentivirus-mediated transduction could result 
in transgene expression in up to 48% of cells on day 7, and after mechanical 
selective weekly passage of regions of hES colonies that are eGFP-positive for 
7 weeks, 80% of the hES cells expressed the transgene (Gropp et al., 2003). 
Obviously, effective chromosomal integration is one of the major advantages of 
lentivirus vectors in establishing stable cell lines. In our hybrid vector systems, 
the AAV rep gene driven by the AAV p5 promoter was included into the same 
baculoviral vector backbone together with the transgene. With these systems, 
a unique transgene expression profile was observed. There was no obvious 
eGFP expression on days 1 and 2 after transduction, probably because of the 
slow process of Rep-mediated chromosomal integration. Without any drug 
selection pressure, transgene expression began to appear on day 3; the 
population of eGFP-positive hES cells reached around 2% on day 7 as 
estimated using fluorescence microscopy (data not shown). This percentage 
could be a rough estimate of the integration rate of our hybrid vectors in the 
original hES cell population. It also reflects the number of stable integrants 
because at this time point the native baculovirus vector-mediated transient 
gene expression has already been silenced. Thus, the hybrid vector-mediated 
integration rate is much higher than that produced by the chemical-based, 
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plasmid transfection method but still lower than that provided by 
lentivirus-based vectors. When we used eGFP as a reporter gene, this 
integration rate was already high enough to allow us to enrich for those stably 
expressing cells manually without the use of drug selection. 
Several methods could be used to limit the duration and intensity of Rep 
expression, thus improving the efficiency of Rep-mediated chromosomal 
integration. These include (a) expressing the rep gene from an inducible 
promoter to control the duration of Rep action, (b) delivering the rep gene into 
hES cells using a separate vector to manipulate the number of copies of the 
rep gene transferred into one hES cell, and (c) direct delivery of the Rep 
protein rather than the rep gene into hES cells, in which the amount of the Rep 
protein in one hES cell could be controlled in a more precise way, and 
Rep-mediated integration would be terminated upon degradation of the protein. 
The co-transduction method mediated stable transgene expression 
comparable to that achieved using the single-vector approach; however, the 
ratio of the two vectors could be optimized to yield higher integration efficiency, 
thus facilitating the subsequent analysis of genomic DNA. hES cell lines that 
can survive drug selection and produce pure clones will also aid the further 




THE EFFECTS OF BACULOVIRAL TRANSDUCTION ON 
HUMAN EMBRYONIC STEM CELLS 
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4.1 Introduction and Objective 
While the efficiency and delivery capacity are important properties of 
vectors used for genetic modification, the effects of such genetic modification 
must also be taken into account. Human embryonic stem cells can be 
genetically modified without losing their pluripotency and the gene transfer 
techniques developed for this purpose include transient transfection, random 
transgenesis, viral integration, site-specific integration and homologous 
recombination (Strulovici et al., 2007). Since we have developed baculovirus 
vectors as a new tool for the genetic modification of human embryonic stem 
cells, it is necessary to investigate the effect for the baculoviral transduction 
in addition to the effects of transgene expression. 
This chapter describes the effects of baculoviral transduction on the 
transduced human embryonic stem cells. Whether the transduced hES cells 
still maintain their self-renewal capacity and whether their pluripotency is 
affected will be discussed. The aim of this study was to investigate the effects 
of baculoviral transduction on hES cells. The results in this chapter will reveal 
whether baculovirus vectors can be applied routinely for the purpose of 
genetic modification purpose.  
4.2 Materials and Methods 
4.2.1 Vector Construction and Virus Preparation 
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To test the effects of baculoviral transduction on the transduced hES cells, 
the vectors developed in Chapter 3 were concentrated and used for hES cell 
transductions (see Chapter 3.2.1).  
4.2.2 Maintenance and Differentiation of hES Cells  
The NIH Human Embryonic Stem Cell Registry-listed hES cell line HES-1 
(Reubinoff et al., 2000) and its feeder cells (K4 mouse embryonic fibroblasts, 
mEFs) were obtained from ES Cell International (ESI; Singapore, 
http://www.escellinternational.com). The hES cells were amplified and 
maintained according to the protocol provided by ES Cell International. For 
viral transduction experiments, this HES-1 line was cultured on mitotically 
inactivated mEFs (CF-1 from American Type Culture Collection, Manassas, 
VA, http://www.atcc.org) seeded in gelatine-coated dishes in 80% knockout 
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supplemented with 
20% Knockout Serum Replacement (Invitrogen), 2 mM L-glutamine 
(Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), and 0.1 mM 
2-mercaptoethanol (Invitrogen), and 4 ng/mL basic fibroblast growth factor 
(bFGF) (Invitrogen), 50 U/mL penicillin, and 50 µg/mL streptomycin (Pomp et 
al., 2005). The hES colonies were subcultured every 7 days by mechanical 
slicing and replating into fresh feeder layers. To form embryoid bodies (EBs), 
hES cells were grown to form large colonies and detached by using 0.1 mg/ml 
Dispase (Invitrogen). The hES cell clumps were transferred to a 15-ml conical 
tube containing 10 ml of a differentiation medium consisting of 80% knockout 
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DMEM, 20% fetal bovine serum (Hyclone, Logan, UT, 
http://www.hyclone.com), 2 mM L-glutamine, and 0.1 mM nonessential amino 
acids and allowed to settle to the bottom. The supernatant was removed. The 
cell clumps were resuspended in the differentiation medium and transferred to 
a Petri dish. The cells were fed every day by replacing half of the medium with 
fresh differentiation medium and were cultured for 1 week.  
The derivation of neurons from hES cells was achieved based on the 
method described by Reubinoff et al (Reubinoff et al., 2001). In brief, hES cell 
differentiation was induced by prolonged culture for 3–4 weeks on feeders. The 
distinct areas of uniformly white-gray and opaque appearance under dark-field 
stereomicroscopy were cut and dissected into small-cell clumps. These cell 
clumps were then transferred to a low-cell-binding 6-well plates (Nalge Nunc 
International, Rochester, NY, http://www.nuncbrand.com) containing DMEM/ 
Ham’s F12 medium (1:1; Invitrogen) supplemented with B-27 (1:50; Invitrogen), 
2 mM L-glutamine, 50 U/mL penicillin, 50 µg/mLstreptomycin, 20 ng/mL human 
epidermal growth factor (EGF) (Chemicon, Temecula, CA, 
http://www.chemicon.com) and 20 ng/mL bFGF (Chemicon). After culture for 
1–3 weeks, round neural spheres were formed. The spheres were then plated 
into dishes coated with poly(D-lysine) (Sigma-Aldrich, St. Louis, 
http://www.sigmaaldrich.com) and laminin (Sigma-Aldrich). Neuronal 
differentiation was induced by the withdrawal of the growth factors from the 
culture medium. 
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4.2.3 Viral Transduction  
For viral transduction, hES cell clumps in suspension were used in order 
to eliminate virus absorption by mEFs (Gropp et al., 2003). At the time of 
routine passage, hES cell clumps were isolated from hES colonies by 
mechanical slicing. For each transduction, eight hES clumps were 
suspended in 50 µL knock-out DMEM in an 1.5ml eppendorf tube and 
baculoviral vectors in 50 µL PBS were added at MOI of 100. After incubated 
for 2 h, the clumps were washed with PBS and replated onto fresh feeder 
mEFs.  
4.2.4 Reverse Transcription-PCR Analysis 
Total RNA was extracted from hES cells or EBs using the RNeasy kit from 
QIAGEN (Valencia, CA; http://www.qiagen.com) according to the 
manufacturer’s instructions. First-strand cDNA was synthesized using the 
SuperScript III First-Strand Synthesis System for reverse transcription 
(RT)-PCR (Invitrogen). One microliter of cDNA reaction mix was subjected to 
PCR amplification with the primers listed in Table 3.1. Reactions were 
subjected to 30 PCR cycles after denaturation at 94 °C for 4 minutes as follows: 
94 °C for 30 seconds, 55 °C for 30 seconds, and 72 °C for 60 seconds. An 
additional 5 min extension step at 72 °C for was included at the end of the 30th 










Table 4.1 RT-PCR Primers 






















































4.2.5 Immunohistochemistry and Karyotypic Analysis 
For hES cell immunostaining, the colonies were washed with PBS and fixed 
with ice-cold absolute methanol for 15 min. This was followed by 
permeabilization with PBS containing 0.1% Triton X-100 for 30 s and blocking 
with 1% bovine serum albumin in PBS for 30 minutes. Primary monoclonal 
antibodies against hES cell marker TRA-1-60 (Santa Cruz Biotechnology, 
Santa Cruz, CA, http://www.scbt.com) or TRA-1-81 (Santa Cruz Biotechnology) 
were used to incubate with the samples for 1 h. After washing, the goat 
anti-mouse IgM-PE secondary antibodies (Santa Cruz Biotechnology) were 
used for localization. To detect eGFP protein, Alexa Fluor 488-labeled rabbit 
anti-GFP antibody (Invitrogen) was included for double immunostaining. The 
samples were counterstained with Hoechst stain before observation. Likewise, 
the hES cell-derived neurons were analyzed by indirect immunostaining using 
the primary rabbit antibody against 200 kDa neurofilament (NF200) (Sigma) 
and the secondary swine anti-rabbit Ig/ tetramethylrhodamine B isothiocyanate 
antibody (DAKO, Glostrup, Denmark, http://www.dako.com). 
4.2.6 Teratoma Formation 
For hES cell immunofluorescent staining, the transduced hES cells were 
washed with PBS and fixed with ice-cold absolute methanol for 15 min. This 
was followed by permeabilization with PBS containing 0.1% Triton X-100 for 
30 s and blocking with 1% BSA in PBS for 30 min. The samples were 
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incubated with primary monoclonal antibodies against hES cell marker 
TRA-1-60 for 1 h. After washing, goat anti-mouse IgM-PE (Santa Cruz 
Biotechnology) secondary antibodies were used for localization. To detect 
eGFP protein, Alexa Fluor 488 labeled rabbit anti-GFP antibody (Invitrogen 
Molecular Probes) was included for double immunostaining. The samples 
were counterstained with Hoechst before observation. 
To investigate the effect of baculoviral transduction on the pluripotency of 
hES cells, 4×106 baculovirus-infected HES-1 cells were injected into the rear 
legs of 4-week-old severe combined immunodeficient (SCID) mice to test 
their ability to form teratoma. Two months after injection the resulting 
teratomas were removed and fixed in 4% paraformaldehyde, embedded in 
paraffin, cut in 10 µm sections and stained with haematoxylin and eosin. The 
sections were observed using light microscopy. 
4.3 Baculoviral Transduction Has No Effects on hES Cells’ Stem Cell 
Properties 
4.3.1 Baculoviral Transduction Did Not Affect hES Cell Growth 
Baculovirus infection caused no obvious cytotoxic effects on hES cells, 
even at an MOI of 1000. The infected hES cells displayed no morphological 
changes or proliferation defects in comparison with non-infected control hES 
cells (See Figures 2.3 and 3.2). Following transduction with the transient 
expression vectors, transgene expression decreased and became 
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undetectable 7 days post-transduction and the newly generated cells were 
negative for transgene expression. With the hybrid baculovirus vectors, the 
newly generated hES cells at the boundary continued to express the transgene 
expression. The transduced hES cells could be routinely maintained by 
mechanical slicing for 22 successive weeks with no observed morphological 
abnormality. This indicates that baculoviral transduction of hES cells did not 
affect the cells’ growth and that the transduced hES cells can proliferate 
normally while maintaining transgene expression. 
4.3.2 Baculoviral Transduction Did Not Change hES Phenotype 
RT-PCR analysis demonstrated that the baculovirus-infected hES cells 
remained positive for Oct-4 and nanog, two important markers for 
undifferentiated hES cells, but negative for representative markers for the three 
germ layers such as Pax6, NeuroD, globin and AFP (Figure 4.1b) as did their 
non-transduced counterparts (Figure 4.1a). Immunostaining revealed the 
TRA-1-60 and TRA-1-81 expression (Figure 4.1c), further confirming the 
undifferentiated state of these infected hES cells. 
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 Figure 4.1 Effects of baculovirus infection using transient expression 
vectors on the expression of molecular markers for hES cells and the 
three germ layers in embryoid bodies. The hES cell clumps were 
transduced with recombinant baculovirus containing the eGFP gene under 
control of the CMV promoter at an MOI of 100 and replated onto fresh mEF 
feeder cells. Seven days after transduction, RT-PCR (a,b) and 
immunostaining (c) were carried out to detect the expression of molecular 
markers in mock-transduced hES cells (a) and hES cells transduced with 
baculoviral vectors (b,c). Abbreviation: AFP, a-fetoprotein. 
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4.3.3 Baculoviral Transduction Did Not Affect hES Cell Pluripotency 
To determine the effects of baculoviral transduction on hES cell 
pluripotency, the infected hES cells were used to form embryoid bodies. 
RT-PCR analysis showed that these embryoid bodies still expressed markers 
for the three germ layers (Figure 4.2a), as did those generated from the 
mock-infected hES cells (Figure 4.2b), suggesting that the 









Figure 4.2 RT-PCR analysis of markers for the three germ layers of 
baculoviral transduced embryoid bodies. Total RNA was extracted 
from EBs and first-strand cDNA was synthesized for RT-PCR. One 
microliter of cDNA reaction mix was subjected to PCR amplification with 
primers shown in Table 4.1. PCR products were electrophoresed on a 2% 
agarose gel. Abbreviation: AFP, a-fetoprotein. 
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We also confirmed that the stably transduced hES cells grew normally as 
flat colonies resembling their non-transduced hES cells (See Chapter3, 
Figure 3.2c; Figure 4.3a), expressed markers for embryonic stem cells 
(Figure 4.3a), and retained a normal karyotype (Figure 4.3b). These findings, 
plus the above observations that stably transduced hES cells were able to 
differentiate into neurons and cardiomyocytes, indicate that baculoviral 
infection does not affect either the self-renewal capacity or pluripotency of 





Figure 4.3 Effects of baculovirus infection using stable 
expression vectors on the expression of molecular markers and 
the karyotype of stably transduced hES cells. (a) Images of a 
transduced hES cell colony with stable eGFP expression collected at 
15 weeks of continuous passage. (b) SKY analysis of stably 
transduced hES cells after 10 weeks of continuous passage 
demonstrates that the cells are karyotypically normal. A total of 20 
metaphase cells were analyzed. The chromosome pattern is 46, XX. 
No numerical or structural aberrations were observed.  
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Immunostaining demonstrated TRA-1-60 expression in the transduced 
hES cell clumps grown on Matrigel (Figure 4.4a), suggesting the 
undifferentiated state of these hES cells. These results are consistent with 
the well-established observations that baculoviral vectors have limited 
cytotoxic effects on mammalian cells even at a high MOI, which is a desirable 
property for the application of viral vectors in sensitive hES cells. To 
investigate the effect of baculoviral transduction on hES cell pluripotency, 
baculovirus-transduced HES-1 cells were injected into the hind legs of SCID 
mice to form teratomas. The teratomas became apparent 6-8 weeks after 
injection. Differentiation profiles of the resulting teratomas were then 
assessed by histological examination. Figure 4.4b demonstrates the 
presence in the teratoma of cells from all three germ layers, indicating that 






Figure 4.4 Immunostaining and teratoma formation by the 
baculovirus-transduced hES cells. Small HES-1 cell clumps were transduced by 
bacluoviral vectors carrying CMVe.EF1α.eGFP-WPRE at MOI of 100 and seeded 
on Matrigel-coated plates. (A) Immunofluorescence staining of HES-1 cell clump 2 
days after transduction with antibodies against GFP and TRA-1-60. (B) 
Hematoxylin and eosin-staining of tissue sections of teratoma formed by 
baculovirus-transduced HES-1 cells in SCID mice. The histology of differentiated 
tissues found in the teratoma demonstrates neural tissue (ectoderm), striated 
muscle (mesoderm), cartilage (mesoderm), and glandular epithelium (endoderm). 
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4.4 Discussions 
This study confirmed that the baculoviral transduction did not affect the 
transduced cells in term of proliferation or ability to differentiate, which are 
the two most important and interesting characteristics of hES cells. The 
transduced hES cells can proliferate normally after transduction and transient 
or stable expression of the transgene, depending on the vectors used. RT 
PCR analysis and immunostaining showed the transduced cells were 
positive for the tested stem cell markers and when those transduced cells 
were used to form embryoid bodies, they were positive for markers of three 
germ layers. The transduced cells also maintain a normal karotype, 
demonstrating the low genotoxicity of baculovirus vectors to hES cells. 
Moreover, the injection of transduced cells hES into SCID mice induced 
teratoma formation, providing additional evidence that the pluripotency of the 
transduced cells was not affected. 
In summary, baculovirus vectors can be engineered to genetically modify 
hES cells, and the baculoviral transduction does not affect hES cell growth, 






5.1 Results and Implications 
The main purpose of this study was to explore baculovirus as a gene 
delivery vector for the genetic modification of hES cells. We employed 
different promoters and viral modulators, to test baculovirus vectors 
intensively for their ability to mediate efficient but transient transgene 
expression in hES cells. Stable expression was achieved when two elements 
from AAV were incorporated to produce hybrid baculovirus vectors, both for 
the single-vector approach and for co-transduction approach. As described in 
the previous chapters, the research work of this thesis can be divided into 
two parts. In this chapter, the main findings of these two parts of study, 
together with their implications will be discussed. 
5.1.1 Efficient and Controlled Transient Transgene Expression Can be 
Achieved by Using Different Promoters and Genetic Modulators  
As shown in Chapter 2, we have successfully achieved efficient and 
transient transgene expression in hES cells using baculoviral transduction. 
The transgene expression can be seen at various transduction efficiencies 
and levels, depending on the choice of promoters and viral modulators. A 
time-course study showed a gradual decline of the transgene expression, 
which became unobservable 8 days post-transduction. Therefore, baculoviral 
vectors are powerful tools for the genetic modification of hES cells; by 
engineering the expression cassettes, a spectrum of transient transgene 
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expression levels can be obtained. The transient and controllable nature of 
baculovirus makes it very useful for the delivery of genes involved in cell 
differentiation to hES cells. Baculoviral vectors equipped with appropriate 
promoters and viral modulators can be applied to the genetic engineering of 
hES cells to direct their differentiation into different lineages, thus facilitating 
fundamental developmental studies as well as supplying a source of cells for 
the regenerative medicine. 
5.1.2 Hybrid Baculovirus Vectors Allow Stable Transgene Expression 
As presented in Chapter 3, stable transgene expression in hES cells can 
be observed. By using a hybrid virus approach (i.e., by including a rep gene 
and ITR sequences from AAV into the baculovirus), the duration of transgene 
expression in hES cells was extended significantly, so that stably transduced 
hES cells could be selected and expanded. Although lentivirus vectors have 
been most widely used for the genetic modification of hES cells, these 
viruses appear to preferentially integrate into chromatin regions 
characterized by an open structure, a hallmark of actively transcribed genes 
(Cereseto A. et. al, 2004). The hybrid vector contains the AAV ITR sequence 
and the rep gene for targeting and inserting the transgene cassette into a 
defined region on human chromosome19 q13.3. Our study has for the first 
time shown that such a hybrid vector can be used for the long-term 
transgene expression in hES cells. The transgene expression was sustained 
during both cell proliferation and differentiation process. However, the 
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integration sites in hES cells still need to be extensively characterized. mEFs 
that can support the growth of hES cells would aid the selection of pure hES 
cell populations.   
5.1.3 Baculoviral Transduction Has No Effects on the Stem Cell 
Properties of hES Cells 
As demonstrated in Chapter 4, baculoviral transduction did not affect the 
stem cell properties of hES cells. The transduced cells still proliferated 
normally without morphological changes, and maintained markers for 
pluripotency as demonstrated by RT-PCR and immunostaining. They 
differentiated into neuronal cells and cardiomyocytes and maintained their 
normal karyotype. The formation of teratomas was also observed. All these 
results demonstrate that baculoviral transduction has no effect on the 
stemness of hES cells. Thus, baculovirus vectors can safely be sued as 
vectors for the genetic modification of hES cells.  
5.2 Conclusion 
The research work presented in this thesis investigated the use of 
baculovirus as a tool for the genetic modification of human embryonic stem 
cells, for both the transient and stable transgene expression. Moreover, the 
effects of baculoviral transduction on hES cells were also examined 
extensively. The transduced cells still maintained their stem cells properties, 
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indicating that the baculovirus vectors can be used safely to genetically 
modify hES cells.  
The results presented in this thesis suggest that baculovirus is a powerful 
tool for the introduction of transgenes into hES cells. Thus, the genetic 
modification of the hES cells can be achieved. Baculovirus vectors can be 
engineered to realize the great potential of hES cells, advancing the 
understanding of early human development and providing various types of 
cells for regenerative medicine. 
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